###begin article-title 0
ICP0 antagonizes Stat 1-dependent repression of herpes simplex virus: implications for the regulation of viral latency
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 4 31 <span type="species:ncbi:10298">herpes simplex virus type 1</span>
###xml 33 38 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 108 113 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 174 179 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 340 345 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 592 597 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
The herpes simplex virus type 1 (HSV-1) ICP0 protein is an E3 ubiquitin ligase, which is encoded within the HSV-1 latency-associated locus. When ICP0 is not synthesized, the HSV-1 genome is acutely susceptible to cellular repression. Reciprocally, when ICP0 is synthesized, viral replication is efficiently initiated from virions or latent HSV-1 genomes. The current study was initiated to determine if ICP0's putative role as a viral interferon (IFN) antagonist may be relevant to the process by which ICP0 influences the balance between productive replication versus cellular repression of HSV-1.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 15 16 15 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scid </italic>
###xml 73 77 73 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 77 81 77 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 110 112 110 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 178 183 178 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scid </italic>
###xml 186 190 186 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 190 194 190 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 267 271 267 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 271 275 271 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 321 325 314 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 325 329 318 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 329 334 322 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 334 337 327 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 350 354 343 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 354 358 347 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 358 363 351 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 363 366 356 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 390 392 383 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 490 492 483 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 522 530 515 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 29 34 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 81 85 <span type="species:ncbi:10090">mice</span>
###xml 194 198 <span type="species:ncbi:10090">mice</span>
###xml 275 279 <span type="species:ncbi:10090">mice</span>
Wild-type (ICP0+) strains of HSV-1 produced lethal infections in scid or rag2-/- mice. The replication of ICP0- null viruses was rapidly repressed by the innate host response of scid or rag2-/- mice, and the infected animals remained healthy for months. In contrast, rag2-/- mice that lacked the IFN-alpha/beta receptor (rag2-/- ifnar-/-) or Stat 1 (rag2-/- stat1-/-) failed to repress ICP0- viral replication, resulting in uncontrolled viral spread and death. Thus, the replication of ICP0- viruses is potently repressed in vivo by an innate immune response that is dependent on the IFN-alpha/beta receptor and the downstream transcription factor, Stat 1.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 55 63 55 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 346 353 346 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 420 422 420 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 601 603 601 603 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 151 156 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 282 287 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 579 584 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
ICP0's function as a viral IFN antagonist is necessary in vivo to prevent an innate, Stat 1-dependent host response from rapidly repressing productive HSV-1 replication. This antagonistic relationship between ICP0 and the host IFN response may be relevant in regulating whether the HSV-1 genome is expressed, or silenced, in virus-infected cells in vivo. These results may also be clinically relevant. IFN-sensitive ICP0- viruses are avirulent, establish long-term latent infections, and induce an adaptive immune response that is highly protective against lethal challenge with HSV-1. Therefore, ICP0- viruses appear to possess the desired safety and efficacy profile of a live vaccine against herpetic disease.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 166 167 166 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 166 167 166 167 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>i</italic></bold>
###xml 196 198 196 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ii</italic>
###xml 196 198 196 198 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>ii</italic></bold>
Herpesviruses are double-stranded DNA viruses that establish life-long infections in their animal hosts, and which alternate between two programs of gene expression: i. productive replication, or ii. latent infection in which most of the viral genome is transcriptionally silent.
###end p 9
###begin p 10
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 413 414 413 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 532 534 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 579 587 579 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 706 713 706 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 0 22 <span type="species:ncbi:10298">Herpes simplex virus 1</span>
###xml 24 29 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 53 58 <span type="species:ncbi:9606">human</span>
###xml 178 183 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 372 377 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 441 446 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 573 578 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 643 648 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
Herpes simplex virus 1 (HSV-1) and 2 (HSV-2) are the human herpesviruses that cause recurrent cold sores and genital herpes. The regulation of gene expression from the co-linear HSV-1 and HSV-2 genomes has been described in terms of a cascade of expression of immediate-early (IE), early (E), and late (L) genes (Fig. 1A). This model was proposed 30 years ago to describe HSV-1 gene expression in cultured cells [1]. The model predicts that HSV-1 infection of a cell always leads to the production of infectious viral progeny (Fig. 1B). The model is accurate for wild-type HSV-1 in vitro, but fails to account for the most defining feature of HSV-1 and HSV-2: their capacity to establish latent infections in vivo.
###end p 10
###begin p 11
###xml 0 47 0 47 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Two alternative models of HSV-1 gene regulation</bold>
###xml 49 50 49 50 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 114 115 114 115 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 138 139 138 139 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S</sub>
###xml 260 261 260 261 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 282 283 282 283 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S</sub>
###xml 378 380 378 380 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 385 387 385 387 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S </sub>
###xml 566 567 566 567 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 671 672 667 668 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 26 31 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 80 85 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 156 161 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 590 595 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 718 723 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
Two alternative models of HSV-1 gene regulation. A. Genetic organization of the HSV-1 genome. The long-repeated (RL) and short-repeated (RS) regions of the HSV-1 genome regulate expression of 4 of 5 immediate-early (IE) genes (white arrows). The unique long (UL) and unique short (US) regions contain most of the early (E) and late (L) genes (yellow and red arrows). The 15 kb RL and RS regions include a 2 kb recombinogenic 'joint' sequence, the ICP34.5 gene (red arrow), and the LAT and L/ST genes which are repressed during productive replication (black arrows). B. The current model of HSV-1 gene regulation [1] describes a cascade of IE --> E --> L gene expression. C. The proposed Checkpoint model predicts that HSV-1 gene expression proceeds by the accepted cascade, but that viral gene expression can be blocked during viral IE mRNA synthesis if ICP0 is not synthesized (Checkpoint 1) or can be blocked during viral L protein synthesis if ICP34.5 is not synthesized (Checkpoint 2).
###end p 11
###begin p 12
###xml 20 21 20 21 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 198 200 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 221 223 221 223 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 401 403 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 488 489 488 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 490 491 490 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 634 635 634 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 636 637 636 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 812 813 812 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 814 815 814 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 990 991 986 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 992 993 988 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 38 43 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 70 75 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 717 722 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 805 810 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
The long-repeated, RL, regions of the HSV-1 genome appear to regulate HSV-1's capacity to alternate between two programs of gene expression: productive replication or non-productive infection (Fig. 1A). Each copy of the RL region encodes the latency-associated transcript (LAT), the long-short spanning transcript (L/ST), infected cell protein 0 (ICP0), and infected cell protein 34.5 (ICP34.5) (Fig. 1A). Both the LAT and L/ST genes produce RNA transcripts that encode no known protein [2,3]. A viral protein, ICP4, blocks the transcription of the LAT and L/ST genes during productive replication by binding the 5' end of each gene [3,4]. The ICP0 and ICP34.5 genes, which lie on the opposite strand of DNA, promote HSV-1 replication. ICP0 is an E3 ubiquitin ligase that overcomes cellular repression of HSV-1 [5,6]. ICP34.5 antagonizes protein kinase R (PKR)-induced shutoff of viral protein translation by inducing the dephosphorylation of the translation initiation factor, eIF-2alpha [7,8].
###end p 12
###begin p 13
###xml 151 152 151 152 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 218 219 218 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 289 290 289 290 <underline xmlns:xlink="http://www.w3.org/1999/xlink">s</underline>
###xml 296 297 296 297 <underline xmlns:xlink="http://www.w3.org/1999/xlink">t</underline>
###xml 311 312 311 312 <underline xmlns:xlink="http://www.w3.org/1999/xlink">a</underline>
###xml 324 325 324 325 <underline xmlns:xlink="http://www.w3.org/1999/xlink">t</underline>
###xml 521 523 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 649 652 642 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">or </italic>
###xml 649 652 642 645 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>or </italic></bold>
###xml 673 675 662 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 701 703 690 692 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 713 715 702 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 815 824 797 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 825 827 807 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 828 830 810 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 851 853 833 835 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 864 866 846 848 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 945 947 920 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 948 950 923 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 21 26 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 88 93 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 539 544 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 691 696 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 939 943 <span type="species:ncbi:10090">mice</span>
The current model of HSV-1 gene regulation ascribes no significance to the genes in the HSV-1 latency-associated locus, and fails to explain why both RL-encoded proteins function as viral interferon (IFN) antagonists [9-11]. When IFNs bind their cognate receptors at the cell surface, the signal transducer and activator of transcription 1 (Stat 1) protein is phosphorylated and acts in concert with other transcription factors to induce IFN-stimulated gene expression, thus creating an antiviral state in the host cell [12,13]. Wild-type HSV-1 is remarkably resistant to the antiviral state induced by activation of either IFN-alpha/beta receptors or IFN-gamma receptors [14]. In contrast, HSV-1 ICP0- or ICP34.5- mutants are hypersensitive to the antiviral state induced by activation of IFN-alpha/beta receptors in vitro [14-16]. Reciprocally, ICP0- and ICP34.5- viruses exhibit improved replication in IFN-alpha/beta receptor-knockout mice [11,17].
###end p 13
###begin p 14
###xml 75 76 75 76 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 238 245 238 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 180 185 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 307 312 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
The opposing forces produced by IFN-inducible cellular repressors and the RL-encoded viral IFN antagonists, ICP0 and ICP34.5, may form two checkpoints that regulate whether or not HSV-1 completes its replication cycle in an infected cell in vivo. This hypothesis can be integrated into the current model of HSV-1 gene regulation via two modifications (Fig. 1C):
###end p 14
###begin p 15
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink">1</bold>
1. ICP0 and IFN-inducible cellular repressor(s) form an ON-OFF switch that controls whether or not viral IE mRNA synthesis occurs in an infected cell (Checkpoint 1).
###end p 15
###begin p 16
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink">2</bold>
2. ICP34.5 and an IFN-inducible cellular repressor, PKR, form an ON-OFF switch that controls whether or not viral L protein synthesis occurs in an infected cell (Checkpoint 2).
###end p 16
###begin p 17
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 338 340 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
The OFF event at Checkpoint 1 is predicted to occur when ICP0 is not synthesized, and the host IFN response stably represses viral IE mRNA synthesis [14,15]. The OFF event at Checkpoint 2 is predicted to occur when ICP34.5 is not synthesized, and the host IFN response acts through PKR to induce the shutoff of viral L protein synthesis [11,18].
###end p 17
###begin p 18
###xml 199 209 199 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">expressed </italic>
###xml 237 247 237 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">repressed </italic>
###xml 294 301 294 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 542 550 542 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 556 558 556 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 638 640 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 641 643 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 644 646 644 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 734 735 734 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 734 735 734 735 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>i</italic></bold>
###xml 741 743 741 743 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 817 824 817 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 830 832 830 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ii</italic>
###xml 830 832 830 832 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>ii</italic></bold>
###xml 838 840 838 840 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 84 89 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 183 188 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 274 279 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 536 541 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
The proposed Checkpoint Model represents an attempt to explain how the genes in the HSV-1 latency-associated locus may influence the decision-making process that dictates whether the HSV-1 genome is expressed (productive replication) or repressed (quiescent infection) when HSV-1 enters a cell in vivo. The evidence that supports the model is circumstantial, and thus the accuracy of the model is questionable. For example, the Checkpoint Model assumes that the primary function of ICP0 lies in antagonizing IFN-inducible repression of HSV-1 in vivo (Fig. 1C). Several observations are consistent with, but do not prove, this hypothesis [14,15,17]. The current study was initiated to test two key predictions of the Checkpoint Model: i. ICP0- mutants should be susceptible to repression by the innate immune response in vivo, and ii. ICP0- mutants should replicate efficiently and be fully virulent in hosts that are IFN-unresponsive.
###end p 18
###begin p 19
###xml 78 84 78 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prove </italic>
###xml 106 114 106 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 193 201 193 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 395 402 395 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 508 516 508 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 612 620 612 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 642 644 642 644 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 813 815 813 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 34 39 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 126 131 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 309 314 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 490 495 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 632 637 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 721 726 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
Given the extensive literature on HSV-1, no one manuscript can satisfactorily prove the accuracy of a new in vivo paradigm of HSV-1 gene regulation. On the other hand, the need for an improved in vivo model is clear. A model is needed which identifies the host and/or viral factors that can influence whether HSV-1 infection of a cell leads to productive replication or non-productive infection in vivo. The goals of the current study are to introduce the possibility that the cessation of HSV-1 replication in vivo may be regulated by an equilibrium between the host IFN response and viral IFN antagonists. The in vivo behavior of HSV-1 ICP0- mutants is described, which is inexplicable in terms of the current model of HSV-1 gene regulation, but which logically follows from the proposed Checkpoint Model (Fig. 1C). The evidence that supports this newly proposed model is discussed.
###end p 19
###begin title 20
Results
###end title 20
###begin title 21
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scid</italic>
###xml 31 36 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
Failure to express ICP0 allows HSV-1 to be stably repressed in scid mice
###end title 21
###begin p 22
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scid</italic>
###xml 78 80 78 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 108 110 108 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 142 143 142 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 338 343 338 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scid </italic>
###xml 371 373 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 399 401 399 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 536 541 536 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scid </italic>
###xml 611 613 611 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 711 716 711 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scid </italic>
###xml 831 836 831 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scid </italic>
###xml 890 892 890 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
###xml 98 103 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 252 256 <span type="species:ncbi:10090">mice</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 541 545 <span type="species:ncbi:10090">mice</span>
###xml 651 656 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 716 720 <span type="species:ncbi:10090">mice</span>
###xml 768 773 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 836 840 <span type="species:ncbi:10090">mice</span>
BALB/c severe-combined immunodeficient (scid) mice were inoculated with 2 x 105 pfu per eye of an HSV-1 ICP0- virus, n212 (described in Table 1). At 2 and 12 hours post inoculation (p.i.), infectious virus was not detectable in the ocular tear film of mice. At 24 hours p.i., an average of 3000 pfu of n212 was recovered from the eyes of scid mice (black circles in Fig. 2A). Replication of the ICP0- virus remained low to undetectable between days 3 and 70 p.i., and the n212 infection produced no disease. Thus, 100% of n212-infected scid mice remained healthy and survived for 70 days p.i. (red line in Fig. 2A). Secondary challenge with wild-type HSV-1 strain KOS on day 70 p.i. verified that n212-infected scid mice had not mounted an adaptive immune response to HSV-1. KOS sustained high levels of replication in the eyes of scid mice, and produced a uniformly lethal infection (Fig. 2A).
###end p 22
###begin p 23
###xml 12 16 <span type="species:ncbi:10090">mice</span>
Viruses and mice used in this study.
###end p 23
###begin p 24
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
###xml 6 11 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 127 132 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 179 182 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
a The HSV-1 recombinant virus KOS-GFP contains a 2.0 kbp insertion in the intergenic region between the UL26 and UL27 genes of HSV-1 strain KOS, which contains a cytomegalovirus (CMV) IE promoter driving the expression of the green-fluorescent protein (GFP).
###end p 24
###begin p 25
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b </sup>
###xml 10 12 10 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 58 61 58 61 <underline xmlns:xlink="http://www.w3.org/1999/xlink">tag</underline>
###xml 63 66 63 66 <underline xmlns:xlink="http://www.w3.org/1999/xlink">tag</underline>
###xml 68 71 68 71 <underline xmlns:xlink="http://www.w3.org/1999/xlink">tag</underline>
###xml 106 111 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
b The ICP0- null mutant n212 contains a 14 bp insertion, ctagactagtctag, in codon 212 of the ICP0 gene of HSV-1 strain KOS, which inserts stop codons into all three open-reading frames of the ICP0-encoding DNA strand. Illustrated in Figure 4.
###end p 25
###begin p 26
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c </sup>
###xml 10 12 10 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 25 26 25 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 94 99 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
c The ICP0- null mutant 0--GFP contains an ~770 bp insertion in codon 105 of the ICP0 gene of HSV-1 strain KOS, which inserts a GFP coding sequence and 'taa' terminator codon into the ICP0 open-reading frame. Illustrated in Figure 4.
###end p 26
###begin p 27
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">d </sup>
###xml 10 12 10 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 59 62 59 62 <underline xmlns:xlink="http://www.w3.org/1999/xlink">tag</underline>
###xml 63 66 63 66 <underline xmlns:xlink="http://www.w3.org/1999/xlink">taa</underline>
###xml 67 70 67 70 <underline xmlns:xlink="http://www.w3.org/1999/xlink">tag</underline>
###xml 107 112 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
d The ICP4- null mutant n12 contains a 16 bp insertion, ggctagttaactagcc, in codon 262 of the ICP4 gene of HSV-1 strain KOS, which inserts stop codons into all three open-reading frames of the ICP4-encoding DNA strand.
###end p 27
###begin p 28
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">e </sup>
###xml 2 6 2 6 <underline xmlns:xlink="http://www.w3.org/1999/xlink">SCID</underline>
###xml 8 9 8 9 <underline xmlns:xlink="http://www.w3.org/1999/xlink">s</underline>
###xml 15 16 15 16 <underline xmlns:xlink="http://www.w3.org/1999/xlink">c</underline>
###xml 24 25 24 25 <underline xmlns:xlink="http://www.w3.org/1999/xlink">i</underline>
###xml 30 31 30 31 <underline xmlns:xlink="http://www.w3.org/1999/xlink">d</underline>
###xml 206 211 206 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scid </italic>
###xml 211 215 <span type="species:ncbi:10090">mice</span>
e SCID: severe-combined immunodeficiency is a phenotype that results from any one of dozens of genetic mutations that block lymphocyte maturation. The genetic lesion that accounts for the SCID phenotype of scid mice lies in the gene that encodes the catalytic subunit of the DNA-dependent protein kinase. This protein is necessary to repair double-stranded DNA breaks, and is essential to complete V-D-J recombination of either the T cell receptor gene or the B cell receptor gene.
###end p 28
###begin p 29
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f </sup>
###xml 2 5 2 5 <underline xmlns:xlink="http://www.w3.org/1999/xlink">PML</underline>
###xml 63 64 63 64 <underline xmlns:xlink="http://www.w3.org/1999/xlink">p</underline>
###xml 66 67 66 67 <underline xmlns:xlink="http://www.w3.org/1999/xlink">m</underline>
###xml 77 78 77 78 <underline xmlns:xlink="http://www.w3.org/1999/xlink">l</underline>
f PML: a protooncogene which, when mutated, is associated with promyelocytic leukemia.
###end p 29
###begin p 30
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g </sup>
###xml 2 6 2 6 <underline xmlns:xlink="http://www.w3.org/1999/xlink">RAG2</underline>
###xml 8 9 8 9 <underline xmlns:xlink="http://www.w3.org/1999/xlink">r</underline>
###xml 22 23 22 23 <underline xmlns:xlink="http://www.w3.org/1999/xlink">a</underline>
g RAG2: recombination-activated gene 2, which encodes a protein necessary to initiate V-D-J recombination of the T cell receptor gene or B cell receptor gene.
###end p 30
###begin p 31
###xml 7 9 7 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 31 36 31 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scid </italic>
###xml 0 40 0 40 <bold xmlns:xlink="http://www.w3.org/1999/xlink">An ICP0<sup>- </sup>virus is avirulent in <italic>scid </italic>mice</bold>
###xml 42 43 42 43 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 45 50 45 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Scid </italic>
###xml 82 84 82 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 107 109 107 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 283 288 281 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scid </italic>
###xml 356 361 354 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scid </italic>
###xml 393 395 391 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 602 603 600 601 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 636 641 634 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scid </italic>
###xml 734 736 730 732 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
###xml 127 131 <span type="species:ncbi:10090">mice</span>
###xml 199 204 <span type="species:ncbi:10090">mouse</span>
###xml 288 292 <span type="species:ncbi:10090">mice</span>
###xml 361 365 <span type="species:ncbi:10090">mice</span>
###xml 420 425 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 624 628 <span type="species:ncbi:10090">mice</span>
###xml 641 645 <span type="species:ncbi:10090">mice</span>
###xml 751 755 <span type="species:ncbi:10090">mice</span>
###xml 803 807 <span type="species:ncbi:10090">mice</span>
An ICP0- virus is avirulent in scid mice. A. Scid mice were inoculated with 2 x 105 pfu per eye of the ICP0- virus n212 (n = 6 mice). The mean +/- sem of the logarithm of viral titers recovered from mouse eyes is plotted over time (open black symbols). The survival of n212-infected scid mice is plotted over time (red line). On day 70 p.i., n212-infected scid mice were challenged with 2 x 105 pfu per eye of wild-type HSV-1 strain KOS (subsequent viral titers are shown as open blue symbols). The dashed line indicates the lower limit of detection of the plaque assay used to determine viral titers. B. Survival of BALB/c mice versus scid mice infected with KOS or n212. Bars represent the mean +/- sem of survival frequency of ICP0- virus-infected mice at day 60 p.i. (n = 5 experiments; Sigman = 30 mice per group).
###end p 31
###begin p 32
###xml 44 46 44 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 74 79 74 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scid </italic>
###xml 158 163 158 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scid </italic>
###xml 174 176 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 264 269 264 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scid </italic>
###xml 283 284 283 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 283 284 283 284 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>i</italic></bold>
###xml 353 358 353 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scid </italic>
###xml 391 393 391 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ii</italic>
###xml 391 393 391 393 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>ii</italic></bold>
###xml 544 547 544 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">iii</italic>
###xml 544 547 544 547 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>iii</italic></bold>
###xml 577 582 577 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scid </italic>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
###xml 163 167 <span type="species:ncbi:10090">mice</span>
###xml 269 273 <span type="species:ncbi:10090">mice</span>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
###xml 582 586 <span type="species:ncbi:10090">mice</span>
###xml 630 634 <span type="species:ncbi:10090">mice</span>
Multiple experiments confirmed that the ICP0- virus n212 was avirulent in scid mice, whereas the wild-type KOS strain produced uniformly lethal infections in scid mice (Fig. 2B). Moreover, n212 appeared to rapidly exit the productive cycle of viral replication in scid mice based on i. low to undetectable levels of infectious virus in the tear film of scid mice between 3 and 70 days p.i., ii. undetectable levels of infectious virus in homogenates of eyes or trigeminal ganglia (TG) at 35 or 70 days p.i. (n = 10 tissues per time point), and iii. the fact that n212-infected scid mice remained indistinguishable from uninfected mice for more than 2 months p.i.
###end p 32
###begin title 33
###xml 4 11 4 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 30 32 30 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
The in vivo repression of ICP0- viruses is Stat 1-dependent
###end title 33
###begin p 34
###xml 49 51 49 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 52 54 52 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 125 127 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 206 208 206 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 221 228 221 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 269 271 269 271 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 350 354 350 354 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 355 359 355 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 359 362 359 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 373 377 373 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 386 391 386 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 391 395 391 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 420 421 420 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 457 459 457 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 488 490 488 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 591 593 591 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 675 680 675 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 680 684 680 684 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 733 735 733 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 744 748 744 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 748 752 748 752 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 831 836 831 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 836 840 836 840 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 964 967 964 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PML</italic>
###xml 967 971 967 971 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1082 1086 1082 1086 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 1086 1090 1086 1090 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1101 1103 1101 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 175 179 <span type="species:ncbi:10090">mice</span>
###xml 196 201 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 314 318 <span type="species:ncbi:10090">mice</span>
###xml 364 368 <span type="species:ncbi:10090">mice</span>
###xml 377 381 <span type="species:ncbi:10090">mice</span>
###xml 395 399 <span type="species:ncbi:10090">mice</span>
###xml 478 483 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 563 567 <span type="species:ncbi:10090">mice</span>
###xml 684 688 <span type="species:ncbi:10090">mice</span>
###xml 722 726 <span type="species:ncbi:10090">mice</span>
###xml 752 756 <span type="species:ncbi:10090">mice</span>
###xml 840 844 <span type="species:ncbi:10090">mice</span>
###xml 971 975 <span type="species:ncbi:10090">mice</span>
###xml 1073 1077 <span type="species:ncbi:10090">mice</span>
###xml 1090 1094 <span type="species:ncbi:10090">mice</span>
To determine if the IFN-induced antiviral state [19,20] or the IFN-induced pro-myelocytic leukemia (PML)-associated protein [21] is relevant to the innate mechanisms by which mice rapidly repress HSV-1 ICP0- null mutants in vivo, the acute ocular replication of an ICP0- virus was compared in wild-type strain 129 mice, recombination-activated gene 2-/- (rag2-/-) mice, PML-/- mice, or stat1-/- mice (described in Table 1). Following inoculation with 2 x 105 pfu per eye of the HSV-1 ICP0- virus n212, ~1000 pfu per eye of virus was recovered from all strains of mice at 24 hours p.i. (Fig. 3A). On day 3 p.i., titers of infectious n212 were ~1000-fold higher in the eyes of stat1-/- mice relative to the other strains of mice (Fig. 3A). While rag2-/- mice survived n212 infection for >60 days, n212 infection was lethal in 3 of 4 stat1-/- mice by day 12 p.i. Loss of Stat 1 alleviated host repression of n212, but loss of PML did not produce a comparable effect. PML-/- mice repressed n212 replication at the site of ocular inoculation with the same kinetics as wild-type mice and rag2-/- mice (Fig. 3A).
###end p 34
###begin p 35
###xml 56 58 56 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 66 73 66 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 0 73 0 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Loss of Stat 1 alleviates innate host repression of ICP0<sup>- </sup>viruses <italic>in vivo</italic></bold>
###xml 75 76 75 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 95 99 95 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 99 103 99 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 109 112 109 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PML</italic>
###xml 112 116 112 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 125 130 125 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 130 134 130 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 166 168 166 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 191 193 191 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 326 327 324 325 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 346 350 344 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 350 354 348 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 360 365 358 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 365 369 363 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 378 382 376 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 382 386 380 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 386 391 384 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 391 395 389 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 427 429 425 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 452 454 450 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 462 463 460 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 564 565 562 563 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 596 600 594 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 600 604 598 602 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 610 613 608 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PML</italic>
###xml 613 617 611 615 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 623 628 621 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 628 632 626 630 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 641 645 639 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 645 649 643 647 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 649 654 647 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 654 658 652 656 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 685 687 683 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 705 706 703 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 773 775 769 771 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 89 93 <span type="species:ncbi:10090">mice</span>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 134 138 <span type="species:ncbi:10090">mice</span>
###xml 211 215 <span type="species:ncbi:10090">mice</span>
###xml 293 298 <span type="species:ncbi:10090">mouse</span>
###xml 340 344 <span type="species:ncbi:10090">mice</span>
###xml 354 358 <span type="species:ncbi:10090">mice</span>
###xml 369 373 <span type="species:ncbi:10090">mice</span>
###xml 395 399 <span type="species:ncbi:10090">mice</span>
###xml 475 479 <span type="species:ncbi:10090">mice</span>
###xml 590 594 <span type="species:ncbi:10090">mice</span>
###xml 604 608 <span type="species:ncbi:10090">mice</span>
###xml 617 621 <span type="species:ncbi:10090">mice</span>
###xml 632 636 <span type="species:ncbi:10090">mice</span>
###xml 658 662 <span type="species:ncbi:10090">mice</span>
###xml 790 794 <span type="species:ncbi:10090">mice</span>
###xml 842 846 <span type="species:ncbi:10090">mice</span>
Loss of Stat 1 alleviates innate host repression of ICP0- viruses in vivo. A. Strain 129 mice, rag2-/- mice, PML-/- mice, or stat1-/- mice were inoculated with 2 x 105 pfu per eye of the ICP0- virus n212 (n = 4 mice per group). The mean +/- sem of the logarithm of viral titers recovered from mouse eyes is plotted over time. B. Strain 129 mice, rag2-/- mice, stat1-/- mice, or rag2-/- stat1-/- mice were inoculated with 2 x 105 pfu per eye of the ICP0- virus, 0--GFP (n = 4 mice per group). Dashed lines indicate the lower limit of detection of the plaque assay. C. Survival of strain 129 mice, rag2-/- mice, PML-/- mice, stat1-/- mice, or rag2-/- stat1-/- mice infected with the ICP0- viruses, n212 or 0--GFP. Bars represent the mean +/- sem of survival frequency of ICP0- virus-infected mice at day 60 p.i. (n = 3 experiments; Sigman = 14 mice per group).
###end p 35
###begin p 36
###xml 75 76 75 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 156 164 156 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 213 215 213 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 302 307 302 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 307 311 307 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 364 366 364 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 374 375 374 375 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 386 387 386 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 408 409 408 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 452 453 452 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 505 509 505 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 509 513 509 513 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 519 524 519 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 524 528 524 528 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 537 541 537 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 541 545 541 545 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 545 550 545 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 550 554 550 554 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 565 567 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 607 608 607 608 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 651 656 651 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 656 660 656 660 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 669 673 669 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 673 677 673 677 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 677 682 677 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 682 686 682 686 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 721 725 721 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 725 729 725 729 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 740 742 740 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 789 794 789 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 794 798 794 798 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 807 811 807 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 811 815 811 815 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 815 820 815 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 820 824 820 824 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 879 880 879 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 898 900 898 900 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 972 973 972 973 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1010 1015 1010 1015 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 1015 1019 1015 1019 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1028 1032 1028 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 1032 1036 1032 1036 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1036 1041 1036 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 1041 1045 1041 1045 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 311 315 <span type="species:ncbi:10090">mice</span>
###xml 499 503 <span type="species:ncbi:10090">mice</span>
###xml 513 517 <span type="species:ncbi:10090">mice</span>
###xml 528 532 <span type="species:ncbi:10090">mice</span>
###xml 554 558 <span type="species:ncbi:10090">mice</span>
###xml 660 664 <span type="species:ncbi:10090">mice</span>
###xml 686 690 <span type="species:ncbi:10090">mice</span>
###xml 713 717 <span type="species:ncbi:10090">mice</span>
###xml 729 733 <span type="species:ncbi:10090">mice</span>
###xml 798 802 <span type="species:ncbi:10090">mice</span>
###xml 824 828 <span type="species:ncbi:10090">mice</span>
###xml 1019 1023 <span type="species:ncbi:10090">mice</span>
###xml 1045 1049 <span type="species:ncbi:10090">mice</span>
The n212 virus bears a small 14 bp linker insertion in the ICP0 gene (Fig. 4), which can revert to a wild-type ICP0 gene by excision of the linker sequence in vivo (unpublished observation). To verify that an ICP0- virus itself, as opposed to a wild-type revertant, was capable of producing disease in stat1-/- mice, a second experiment was performed with the ICP0- virus, 0--GFP (Fig. 4; described in Table 1). At 24 hours p.i., ~1000 pfu per eye of 0--GFP was recovered from the eyes of wild-type mice, rag2-/- mice, stat1-/- mice, or rag2-/- stat1-/- mice (Fig. 3B). On day 3 p.i., titers of infectious 0--GFP were ~1000-fold higher in the eyes of stat1-/- mice and rag2-/- stat1-/- mice relative to wild-type mice or rag2-/- mice (Fig. 3B). At all times p.i., the virus recovered from stat1-/- mice and rag2-/- stat1-/- mice retained the GFP insertion in the ICP0 gene (Fig. 4) based on the GFP+ phenotype of plaques that formed in plaque assays. In this experiment, 0--GFP infection was lethal in 100% of stat1-/- mice and rag2-/- stat1-/- mice by day 12 p.i.
###end p 36
###begin p 37
###xml 5 7 5 7 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 0 13 0 13 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The R<sub>L </sub>region</bold>
###xml 15 16 15 16 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 53 55 53 55 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 231 233 231 233 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 446 447 446 447 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 495 497 495 497 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 515 516 515 516 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 695 696 695 696 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 46 51 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 112 117 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 477 482 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
The RL region. A. Genetic organization of the HSV-1 RL region. Numbers refer to base positions in the prototype HSV-1 genome, and arrows denote the LAT, L/ST, ICP34.5, and ICP0 primary transcripts. Reiterated DNA sequences in the RL region are denoted by small boxes containing vertical bars. The location of the DNA sequences to which ICP4 homodimers bind in the LAT and L/ST genes is denoted by pairs of black ovals at the 5' end of each gene. B. The ICP0 genes of wild-type HSV-1 and the ICP0- viruses n212 and 0--GFP. The mutation in n212 introduces a 14 bp linker sequence into codon 212 of the ICP0 open-reading frame, which terminates protein translation [53]. The insertion mutation in 0--GFP introduces an ~770 bp green-fluorescent protein (GFP) coding sequence in-frame with the ICP0 gene. The resulting mRNA is predicted to encode the N-terminal 104 amino acids of ICP0 fused to a 14 amino acid linker and 239 amino acids of C-terminal GFP.
###end p 37
###begin p 38
###xml 33 35 33 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 53 54 53 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 103 107 103 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 107 111 107 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 121 124 121 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PML</italic>
###xml 124 128 124 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 187 189 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 215 216 215 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 265 270 265 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 270 274 270 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 294 298 294 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 298 302 298 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 302 307 302 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 307 311 307 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 396 400 396 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 400 404 400 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 451 453 451 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 461 468 461 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 97 101 <span type="species:ncbi:10090">mice</span>
###xml 111 115 <span type="species:ncbi:10090">mice</span>
###xml 128 132 <span type="species:ncbi:10090">mice</span>
###xml 150 154 <span type="species:ncbi:10090">mice</span>
###xml 274 278 <span type="species:ncbi:10090">mice</span>
###xml 311 315 <span type="species:ncbi:10090">mice</span>
###xml 404 408 <span type="species:ncbi:10090">mice</span>
In multiple experiments, the ICP0- viruses n212 and 0--GFP did not produce disease in strain 129 mice, rag2-/- mice, and PML-/- mice, and 100% of the mice survived for 60 days p.i. (Fig. 3C). In contrast, n212 and 0--GFP produced lethal infections in 50 to 100% of stat1-/- mice and in 100% of rag2-/- stat1-/- mice (Fig. 3C). Thus, the IFN-activated Stat 1 transcription factor was required for rag2-/- mice to rapidly repress the replication of ICP0- viruses in vivo.
###end p 38
###begin title 39
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 13 16 13 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag2<sup>-/-</sup>stat 1<sup>-/-</sup></italic>
###xml 17 21 <span type="species:ncbi:10090">mice</span>
###xml 60 65 <span type="species:ncbi:9606">human</span>
Rag2-/-stat 1-/- mice die of uncontrolled viral spread, not human handling
###end title 39
###begin p 40
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 50 54 50 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 54 59 54 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 59 63 59 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 236 245 236 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 249 257 249 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 302 304 302 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 312 313 312 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 358 360 358 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 391 392 391 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 395 403 395 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
###xml 441 442 441 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 512 514 512 514 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 552 554 552 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 644 645 634 635 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 662 664 652 654 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 708 710 698 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 860 862 847 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
###xml 179 184 <span type="species:ncbi:9606">human</span>
###xml 348 353 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 736 741 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 893 898 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
Given the severity of the immunodeficiency of rag2-/- stat1-/- mice, mortality in this strain may have been due to secondary infections introduced by corneal scarification and/or human handling. To address this possibility, a series of in vitro and in vivo experiments were performed comparing the ICP0- virus, 0--GFP, to the replication-defective HSV-1 ICP4- virus, n12 (described in Table 1). In vitro, an inoculum of 2.5 pfu per cell of 0--GFP replicated relatively efficiently in Vero cells, whereas the ICP4- virus produced no viral progeny (Fig. 5A). When Vero cells were treated with the IFN-alpha/beta receptor agonist, IFN-beta, both 0--GFP and the ICP4- virus failed to produce viral progeny (Fig. 5B). In contrast, wild-type HSV-1 resisted repression by IFN-beta and was only transiently delayed in its replication relative to untreated cells (Fig. 5B). Thus, ICP0 was required for HSV-1 replication when cultured cells were exposed to the Stat 1 activator, IFN-beta.
###end p 40
###begin p 41
###xml 19 21 19 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 29 31 29 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 0 79 0 79 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Replication of ICP0<sup>- </sup>and ICP4<sup>- </sup>viruses in cell culture and immunodeficient mice</bold>
###xml 97 98 97 98 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 113 114 113 114 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 229 231 226 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 239 240 236 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 257 259 254 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 393 394 388 389 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 396 400 391 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag2</italic>
###xml 400 404 395 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 404 409 399 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 409 413 404 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 422 423 417 418 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 425 429 420 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 429 433 424 428 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 465 467 460 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 490 492 485 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 499 500 494 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 516 518 511 513 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 761 762 754 755 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 789 791 782 784 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 209 214 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 216 219 <span type="species:ncbi:10298">KOS</span>
###xml 413 417 <span type="species:ncbi:10090">mice</span>
###xml 433 437 <span type="species:ncbi:10090">mice</span>
###xml 535 539 <span type="species:ncbi:10090">mice</span>
###xml 617 622 <span type="species:ncbi:10090">mouse</span>
###xml 776 780 <span type="species:ncbi:10090">mice</span>
###xml 806 810 <span type="species:ncbi:10090">mice</span>
Replication of ICP0- and ICP4- viruses in cell culture and immunodeficient mice. Vero cells were A. untreated or B. treated with 200 U per ml of IFN-beta and were inoculated with 2.5 pfu per cell of wild-type HSV-1 (KOS), an ICP0- virus (0--GFP), or an ICP4- virus (n12). The mean +/- sem of the logarithm of viral titers recovered from Vero cells is plotted over time (n = 4 per time point). C. Rag2-/- stat1-/- mice and D. rag2-/- mice were inoculated with 2 x 105 pfu per eye of the ICP0- virus 0--GFP or the ICP4- virus n12 (n = 4 mice per group). The mean +/- sem of the logarithm of viral titers recovered from mouse eyes is plotted over time (open black symbols). Dashed lines indicate the lower limit of detection of each plaque assay. The survival of 0--GFP-infected mice and ICP4- virus-infected mice is plotted over time (open red symbols).
###end p 41
###begin p 42
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo</italic>
###xml 10 11 10 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 61 65 61 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 70 74 70 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
###xml 207 209 207 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 238 242 238 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 242 246 242 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 246 251 246 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 251 255 251 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 263 267 263 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 267 271 267 271 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 296 298 296 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5D</xref>
###xml 383 387 383 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 387 391 387 391 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 468 469 468 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 509 510 509 510 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 524 528 524 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 528 532 528 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 594 596 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5D</xref>
###xml 626 627 626 627 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 654 658 654 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 658 662 658 662 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 662 667 662 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 667 671 667 671 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
###xml 142 146 <span type="species:ncbi:10090">mice</span>
###xml 255 259 <span type="species:ncbi:10090">mice</span>
###xml 271 275 <span type="species:ncbi:10090">mice</span>
###xml 313 317 <span type="species:ncbi:10090">mice</span>
###xml 391 395 <span type="species:ncbi:10090">mice</span>
###xml 532 536 <span type="species:ncbi:10090">mice</span>
###xml 671 675 <span type="species:ncbi:10090">mice</span>
###xml 809 813 <span type="species:ncbi:10090">mice</span>
###xml 823 828 <span type="species:ncbi:9606">human</span>
In vivo, 0--GFP replicated to high titers in the eyes of rag2-/- stat1-/- mice, acute swelling of periocular tissue occurred, and none of the mice survived beyond day 11 p.i. (Fig. 5C). In contrast, the ICP4- virus failed to replicate in rag2-/- stat1-/- mice or rag2-/- mice, and all of the ICP4- virus-infected mice remained healthy for the 30-day test period (Fig. 5C and 5D). In rag2-/- mice, which retained a functional Stat 1 pathway, the ocular replication of 0--GFP was rapidly repressed and 100% of 0--GFP-infected rag2-/- mice remained healthy for the 30-day observation period (Fig. 5D). Thus, the pathogenesis of 0--GFP infection observed in rag2-/- stat1-/- mice appeared to be the result of unchecked viral replication, and was not the result of an unanticipated infection with the flora of the mice or their human handlers.
###end p 42
###begin title 43
###xml 55 62 55 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 42 47 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
Stat 1 is necessary to restrict wild-type HSV-1 spread in vivo
###end title 43
###begin p 44
###xml 111 115 111 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 115 119 115 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 125 130 125 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 130 134 130 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 143 147 143 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 147 151 147 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 151 156 151 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 156 160 156 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 192 194 192 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 281 282 281 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 447 452 447 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 452 456 452 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 460 464 460 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 464 468 464 468 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 468 473 468 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 473 477 473 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 508 512 508 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 512 516 512 516 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 527 529 527 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 612 616 612 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 616 620 616 620 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 669 674 669 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 674 678 674 678 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 687 691 687 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 691 695 691 695 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 695 700 695 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 700 704 700 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 715 717 715 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 794 799 794 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 799 803 799 803 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 807 811 807 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 811 815 811 815 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 815 820 815 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 820 824 820 824 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 855 859 855 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 859 863 859 863 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 874 876 874 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 955 960 955 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 960 964 960 964 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 968 972 968 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 972 976 972 976 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 976 981 976 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 981 985 981 985 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1037 1041 1037 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 1041 1045 1041 1045 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1100 1102 1100 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 1122 1126 1122 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 1126 1130 1126 1130 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1232 1238 1232 1238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A, 6B</xref>
###xml 1310 1315 1310 1315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 1315 1319 1315 1319 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1323 1327 1323 1327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 1327 1331 1327 1331 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1331 1336 1331 1336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 1336 1340 1336 1340 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1372 1374 1372 1374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 77 82 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 105 109 <span type="species:ncbi:10090">mice</span>
###xml 119 123 <span type="species:ncbi:10090">mice</span>
###xml 134 138 <span type="species:ncbi:10090">mice</span>
###xml 160 164 <span type="species:ncbi:10090">mice</span>
###xml 209 212 <span type="species:ncbi:10298">KOS</span>
###xml 257 260 <span type="species:ncbi:10298">KOS</span>
###xml 310 313 <span type="species:ncbi:10298">KOS</span>
###xml 363 367 <span type="species:ncbi:10090">mice</span>
###xml 394 397 <span type="species:ncbi:10298">KOS</span>
###xml 477 481 <span type="species:ncbi:10090">mice</span>
###xml 516 520 <span type="species:ncbi:10090">mice</span>
###xml 620 624 <span type="species:ncbi:10090">mice</span>
###xml 678 682 <span type="species:ncbi:10090">mice</span>
###xml 704 708 <span type="species:ncbi:10090">mice</span>
###xml 731 734 <span type="species:ncbi:10298">KOS</span>
###xml 824 828 <span type="species:ncbi:10090">mice</span>
###xml 863 867 <span type="species:ncbi:10090">mice</span>
###xml 985 989 <span type="species:ncbi:10090">mice</span>
###xml 1045 1049 <span type="species:ncbi:10090">mice</span>
###xml 1130 1134 <span type="species:ncbi:10090">mice</span>
###xml 1159 1162 <span type="species:ncbi:10298">KOS</span>
###xml 1187 1191 <span type="species:ncbi:10090">mice</span>
###xml 1340 1344 <span type="species:ncbi:10090">mice</span>
###xml 1468 1471 <span type="species:ncbi:10298">KOS</span>
###xml 1547 1551 <span type="species:ncbi:10090">mice</span>
To determine if the Stat 1-dependent host response was relevant to wild-type HSV-1 infection, strain 129 mice, rag2-/- mice, stat1-/- mice, or rag2-/- stat1-/- mice were inoculated with 2 x 105 pfu per eye of KOS-GFP, a GFP-expressing recombinant of strain KOS (described in Table 1). On day 1 p.i., titers of KOS-GFP were equivalent in the eyes of all groups of mice (Fig. 6A). On day 3 p.i., KOS-GFP titers were ~100-fold greater in the eyes of stat1-/- and rag2-/- stat1-/- mice relative to wild-type and rag2-/- mice (Fig. 6A). Likewise, GFP fluorescence was nearly undetectable in the eyes of wild-type and rag2-/- mice on day 3 p.i., but persisted in the eyes of stat1-/- mice and rag2-/- stat1-/- mice (Fig. 6B). Infectious KOS-GFP titers were ~10-fold higher on day 5 p.i. in the TG of stat1-/- and rag2-/- stat1-/- mice relative to wild-type and rag2-/- mice (Fig. 6A). Likewise, GFP fluorescence emanated from large tracts of cells in the TG of stat1-/- and rag2-/- stat1-/- mice on day 5 p.i., whereas the TG of wild-type and rag2-/- mice possessed discrete foci of GFP fluorescence (Fig. 6B). In wild-type and rag2-/- mice, only limited spread of KOS-GFP to the hindbrain of mice was observed on days 5 and 7 p.i. (Fig. 6A, 6B). In contrast, GFP expression was evident in the hindbrain of 17 of 20 stat1-/- and rag2-/- stat1-/- mice on days 5 and 7 p.i. (Fig. 6B). Thus, an innate Stat 1-dependent host response is necessary to prevent extensive spread of KOS-GFP infection from the corneal epithelium to the central nervous system of mice.
###end p 44
###begin p 45
###xml 0 108 0 108 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A Stat1-dependent host response restricts the spread of HSV-1 strain KOS-GFP into the central nervous system</bold>
###xml 127 131 127 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 131 135 131 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 141 146 141 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 146 150 146 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 159 163 159 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 163 167 163 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 167 172 167 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 172 176 172 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 208 210 208 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 247 248 247 248 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 507 512 505 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 512 516 510 514 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 523 528 521 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 528 532 526 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 658 659 656 657 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 56 61 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 69 72 <span type="species:ncbi:10298">KOS</span>
###xml 121 125 <span type="species:ncbi:10090">mice</span>
###xml 135 139 <span type="species:ncbi:10090">mice</span>
###xml 150 154 <span type="species:ncbi:10090">mice</span>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
###xml 225 230 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 238 241 <span type="species:ncbi:10298">KOS</span>
###xml 330 335 <span type="species:ncbi:10090">mouse</span>
###xml 690 693 <span type="species:ncbi:10298">KOS</span>
###xml 707 711 <span type="species:ncbi:10090">mice</span>
A Stat1-dependent host response restricts the spread of HSV-1 strain KOS-GFP into the central nervous system. Strain 129 mice, rag2-/- mice, stat1-/- mice, or rag2-/- stat1-/- mice were inoculated with 2 x 105 pfu per eye of HSV-1 strain KOS-GFP. A. The mean +/- sem of the logarithm of viral titers recovered from homogenates of mouse eyes, TG, and hindbrain is plotted as a function of the time p.i. at which tissues were harvested (n = 5 per time point). Asterisks denote significant differences between stat1+/+ versus stat1-/- tissues (p < 0.001, as determined by two-way ANOVA). Dashed lines indicate the lower limit of detection of each plaque assay. B. GFP expression in tissues of KOS-GFP-infected mice. Representative photographs are shown of eyes harvested on day 3 p.i. (4x magnification, 250 ms exposure), TG harvested on day 5 p.i. (2x magnification, 500 ms exposure), and the ventral side of brains harvested on day 7 p.i. (2x magnification, 1000 ms exposure).
###end p 45
###begin title 46
###xml 75 82 75 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 62 67 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
IFN receptors are integral to the innate response that limits HSV-1 spread in vivo
###end title 46
###begin p 47
###xml 128 129 128 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 135 136 135 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 146 147 146 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 208 209 208 209 <bold xmlns:xlink="http://www.w3.org/1999/xlink">1</bold>
###xml 222 223 222 223 <bold xmlns:xlink="http://www.w3.org/1999/xlink">2</bold>
###xml 225 229 225 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 229 232 229 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 234 235 234 235 <bold xmlns:xlink="http://www.w3.org/1999/xlink">3</bold>
###xml 237 242 237 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifngr</italic>
###xml 242 246 242 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 273 274 269 270 <bold xmlns:xlink="http://www.w3.org/1999/xlink">4</bold>
###xml 276 281 272 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 281 285 277 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 317 318 306 307 <bold xmlns:xlink="http://www.w3.org/1999/xlink">5</bold>
###xml 320 325 309 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 325 329 314 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 329 334 318 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifngr</italic>
###xml 334 337 323 326 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 339 340 328 329 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6</bold>
###xml 342 347 331 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 347 350 336 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 352 353 341 342 <bold xmlns:xlink="http://www.w3.org/1999/xlink">7</bold>
###xml 355 359 344 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 359 363 348 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 363 368 352 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 368 371 357 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 376 377 365 366 <bold xmlns:xlink="http://www.w3.org/1999/xlink">8</bold>
###xml 379 383 368 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 383 387 372 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 387 392 376 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 392 396 381 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 416 417 405 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 453 455 442 444 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 574 576 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 674 678 663 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 678 681 667 670 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 687 692 676 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifngr</italic>
###xml 692 696 681 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 707 709 696 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 753 759 742 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar </italic>
###xml 762 768 751 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1 </italic>
###xml 895 897 884 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 985 990 974 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 990 993 979 982 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 995 1000 984 989 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 1000 1004 989 993 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1004 1009 993 998 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifngr</italic>
###xml 1009 1012 998 1001 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1014 1019 1003 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 1019 1022 1008 1011 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1024 1028 1013 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 1028 1032 1017 1021 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1032 1037 1021 1026 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 1037 1040 1026 1029 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1046 1050 1035 1039 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 1050 1054 1039 1043 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1054 1059 1043 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 1059 1063 1048 1052 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1119 1120 1108 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 1123 1128 1112 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stat1</italic>
###xml 1128 1132 1117 1121 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1138 1142 1127 1131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 1142 1146 1131 1135 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1146 1151 1135 1140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 1151 1155 1140 1144 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1165 1169 1154 1158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 1169 1173 1158 1162 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1173 1178 1162 1167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 1178 1182 1167 1171 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1356 1357 1345 1346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 1360 1365 1349 1354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ifnar</italic>
###xml 1365 1369 1354 1358 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1369 1374 1358 1363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifngr</italic>
###xml 1374 1378 1363 1367 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1448 1449 1435 1436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 1558 1560 1545 1547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1623 1628 1610 1615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 1628 1632 1615 1619 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1632 1637 1619 1624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifngr</italic>
###xml 1637 1641 1624 1628 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1703 1705 1690 1692 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1856 1861 1843 1848 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 1861 1865 1848 1852 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1865 1870 1852 1857 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifngr</italic>
###xml 1870 1874 1857 1861 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 89 94 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 115 118 <span type="species:ncbi:10298">KOS</span>
###xml 175 179 <span type="species:ncbi:10090">mice</span>
###xml 470 473 <span type="species:ncbi:10298">KOS</span>
###xml 546 550 <span type="species:ncbi:10090">mice</span>
###xml 696 700 <span type="species:ncbi:10090">mice</span>
###xml 727 731 <span type="species:ncbi:10090">mice</span>
###xml 790 793 <span type="species:ncbi:10298">KOS</span>
###xml 910 913 <span type="species:ncbi:10298">KOS</span>
###xml 1063 1067 <span type="species:ncbi:10090">mice</span>
###xml 1090 1094 <span type="species:ncbi:10090">mice</span>
###xml 1132 1136 <span type="species:ncbi:10090">mice</span>
###xml 1155 1159 <span type="species:ncbi:10090">mice</span>
###xml 1182 1186 <span type="species:ncbi:10090">mice</span>
###xml 1378 1382 <span type="species:ncbi:10090">mice</span>
###xml 1396 1399 <span type="species:ncbi:10298">KOS</span>
###xml 1641 1645 <span type="species:ncbi:10090">mice</span>
###xml 1839 1842 <span type="species:ncbi:10298">KOS</span>
###xml 1874 1878 <span type="species:ncbi:10090">mice</span>
To determine if host IFNs are the principal activators of Stat 1-dependent repression of HSV-1, the progression of KOS-GFP (ICP0+) or 0--GFP (ICP0-) infection was compared in mice of the following genotypes: 1. wild-type, 2. rag2-/-, 3. ifngr-/- (IFN-gamma receptor-null), 4. ifnar-/- (IFN-alpha/beta receptor-null), 5. ifnar-/- ifngr-/-, 6. stat1-/-, 7. rag2-/- stat1-/-, or 8. rag2-/- ifnar-/- (described in Table 1). Following inoculation with 2 x 105 pfu per eye of KOS-GFP, similar levels of GFP fluorescence were observed in the corneas of mice at 36 hours p.i. (Fig. 7A). By 60 and 84 hours p.i., GFP fluorescence was nearly undetectable in the corneas of wild-type, rag2-/-, and ifngr-/- mice (Fig. 7A). All strains of mice with a defect in the ifnar or stat1 genes failed to limit KOS-GFP spread, and thus GFP fluorescence was still evident throughout the cornea at 84 hours p.i. (Fig. 7A). Likewise, KOS-GFP titers were an average 10- to 300-times higher in the tear film of ifnar-/-, ifnar-/- ifngr-/-, stat1-/-, rag2-/- stat1-/-, and rag2-/- ifnar-/- mice relative to wild-type mice at 72 hours p.i. (Table 2). Stat1-/- mice, rag2-/- stat1-/- mice, and rag2-/- ifnar-/- mice died of a typical viral encephalitis 8 to 9 days p.i., based on the symptoms of hunched posture, ataxia, and hyperexcitability, which preceded death by ~18 hours (Table 2). Ifnar-/- ifngr-/- mice succumbed to KOS-GFP infection just 5.2 +/- 0.1 days p.i. (Table 2), and presented with acute lethargy ~8 hours prior to death. Consistent with the findings of Luker, et al. [19], dissection at the time of death revealed that the livers of ifnar-/- ifngr-/- mice were visibly discolored and the entire liver mass was GFP+ (not shown). Thus, fulminant viral infection of the liver, and presumably liver failure, appeared to be the primary cause of death in KOS-GFP-infected ifnar-/- ifngr-/- mice.
###end p 47
###begin p 48
###xml 48 53 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
Effect of interferon receptors versus Stat 1 on HSV-1 shedding and the survival of infected mice.
###end p 48
###begin p 49
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
###xml 34 36 34 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 76 77 76 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 2 6 <span type="species:ncbi:10090">Mice</span>
###xml 51 56 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 64 67 <span type="species:ncbi:10298">KOS</span>
a Mice were inoculated with 2 x 105 pfu per eye of HSV-1 strain KOS-GFP or 0--GFP.
###end p 49
###begin p 50
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b </sup>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
b The relationship of the genotype and phenotype of these mice is defined in Table 1.
###end p 50
###begin p 51
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c </sup>
###xml 125 129 <span type="species:ncbi:10090">mice</span>
c The mean +/- standard error of the mean of the logarithm of infectious viral titers recovered from the ocular tear film of mice at day 3 p.i. (n = 6 per group).
###end p 51
###begin p 52
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">d </sup>
###xml 20 24 <span type="species:ncbi:10090">mice</span>
d The percentage of mice that survived until day 60 p.i.
###end p 52
###begin p 53
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">e </sup>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 136 141 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
e The mean +/- standard error of the mean duration of survival of those mice that survived for less than 60 days after inoculation with HSV-1. Groups of mice in which no deaths were recorded were sacrificed on day 60 p.i., and their duration of survival is indicated as "> 60."
###end p 53
###begin p 54
###xml 93 97 <span type="species:ncbi:10090">mice</span>
* p < 0.05 that viral titers on day 3 p.i. were equivalent to those recovered from wild-type mice infected with the same virus, based on one-way ANOVA and Tukey's post hoc t-test.
###end p 54
###begin p 55
###xml 0 14 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8225; </sup>
###xml 99 103 87 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 103 107 91 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 130 134 <span type="species:ncbi:10090">mice</span>
double dagger p < 0.05 that the duration of survival was equivalent to the duration of survival of rag2-/- (lymphocyte-deficient) mice infected with the same virus, based on one-way ANOVA and Tukey's post hoc t-test.
###end p 55
###begin p 56
###xml 103 104 96 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 0 135 0 128 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Loss of IFN-&#945;/&#946; receptors or Stat 1 impairs an innate host response that represses KOS-GFP and 0<sup>-</sup>-GFP at the site of inoculation</bold>
###xml 169 171 162 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 186 187 179 180 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 214 215 207 208 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 225 227 218 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 235 236 228 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 310 314 303 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 314 318 307 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 347 352 340 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifngr</italic>
###xml 352 356 345 349 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 388 393 377 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 393 397 382 386 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 434 439 416 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 439 443 421 425 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 443 448 425 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifngr</italic>
###xml 448 452 430 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 458 463 440 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 463 467 445 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 473 477 455 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 477 481 459 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 481 486 463 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 486 490 468 472 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 500 504 482 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 504 508 486 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 508 513 490 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 513 517 495 499 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 748 749 730 731 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 90 93 <span type="species:ncbi:10298">KOS</span>
###xml 137 141 <span type="species:ncbi:10090">Mice</span>
###xml 189 194 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 202 205 <span type="species:ncbi:10298">KOS</span>
###xml 304 308 <span type="species:ncbi:10090">mice</span>
###xml 318 322 <span type="species:ncbi:10090">mice</span>
###xml 356 360 <span type="species:ncbi:10090">mice</span>
###xml 397 401 <span type="species:ncbi:10090">mice</span>
###xml 452 456 <span type="species:ncbi:10090">mice</span>
###xml 467 471 <span type="species:ncbi:10090">mice</span>
###xml 490 494 <span type="species:ncbi:10090">mice</span>
###xml 517 521 <span type="species:ncbi:10090">mice</span>
###xml 613 618 <span type="species:ncbi:10090">mouse</span>
###xml 719 722 <span type="species:ncbi:10298">KOS</span>
Loss of IFN-alpha/beta receptors or Stat 1 impairs an innate host response that represses KOS-GFP and 0--GFP at the site of inoculation. Mice were inoculated with 2 x 105 pfu per eye of A. HSV-1 strain KOS-GFP, or B. the ICP0- virus, 0--GFP. GFP fluorescence was recorded in the right eyes of strain 129 mice, rag2-/- mice (lymphocyte-deficient), ifngr-/- mice (IFN-gamma receptor-null), ifnar-/- mice (IFN-alpha/beta receptor-null), ifnar-/- ifngr-/- mice, stat1-/- mice, rag2-/- stat1-/- mice, and rag2-/- ifnar-/- mice. Representative photographs are shown of GFP fluorescence in the virus-infected eye of one mouse per group photographed over time at 36, 60, and 84 hours p.i. (4x magnification; 39 ms exposure for KOS-GFP; 63 ms exposure for 0--GFP).
###end p 56
###begin p 57
###xml 33 35 33 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 51 52 51 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 141 142 141 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
###xml 320 324 320 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 324 327 324 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 333 338 333 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifngr</italic>
###xml 338 342 338 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
###xml 388 394 388 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar </italic>
###xml 397 403 397 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1 </italic>
###xml 426 427 426 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
###xml 540 541 540 541 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 614 619 614 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 619 623 619 623 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 623 628 623 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifngr</italic>
###xml 628 631 628 631 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 633 638 633 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 638 641 638 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 643 647 643 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 647 651 647 651 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 651 656 651 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 656 659 656 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 665 669 665 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 669 673 669 673 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 673 678 673 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 678 682 678 682 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 738 739 738 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 801 802 801 802 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 844 848 844 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag2</italic>
###xml 848 852 848 852 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 867 868 867 868 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 946 950 946 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 950 954 950 954 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 954 959 954 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 959 963 959 963 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 972 976 972 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 976 980 976 980 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 980 985 980 985 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 985 989 985 989 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1018 1019 1018 1019 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1041 1042 1041 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 1181 1182 1174 1175 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1202 1206 1195 1199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 1206 1210 1199 1203 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
###xml 342 346 <span type="species:ncbi:10090">mice</span>
###xml 362 366 <span type="species:ncbi:10090">mice</span>
###xml 682 686 <span type="species:ncbi:10090">mice</span>
###xml 709 713 <span type="species:ncbi:10090">mice</span>
###xml 754 758 <span type="species:ncbi:10090">mice</span>
###xml 852 856 <span type="species:ncbi:10090">mice</span>
###xml 963 967 <span type="species:ncbi:10090">mice</span>
###xml 989 993 <span type="species:ncbi:10090">mice</span>
###xml 1210 1214 <span type="species:ncbi:10090">mice</span>
Following inoculation with 2 x 105 pfu per eye of 0--GFP, similar levels of GFP reporter gene expression from the ICP0 gene (diagram in Fig. 4) were observed in the corneas of mice at 36 hours p.i. (Fig. 7B). By 60 and 84 hours p.i., GFP fluorescence decreased to nearly undetectable levels in the corneas of wild-type, rag2-/-, and ifngr-/- mice (Fig. 7B). All mice with a defect in the ifnar or stat1 genes failed to limit 0--GFP spread, and GFP fluorescence was still evident throughout the cornea at 84 hours p.i. (Fig. 7B). Likewise, 0--GFP titers were an average 300 to 1000 times higher in the tear film of ifnar-/- ifngr-/-, stat1-/-, rag2-/- stat1-/-, and rag2-/- ifnar-/- mice relative to wild-type mice at 72 hours p.i. (Table 2). Most of the mice that shed titers of >1000 pfu per eye of 0--GFP on day 3 p.i. died of the infection. Rag2-/- mice survived 0--GFP-infection for 60 days and exhibited no symptoms of disease. In contrast, rag2-/- stat1-/- mice and rag2-/- ifnar-/- mice uniformly succumbed to 0--GFP infection (Table 2). Thus, the IFN-alpha/beta receptor and downstream Stat 1 transcription factor are essential for the innate host response that represses 0--GFP replication in rag2-/- mice.
###end p 57
###begin title 58
###xml 51 56 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
Stat 1 is not essential for the early synthesis of HSV-1 latency-associated transcripts
###end title 58
###begin p 59
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 120 122 120 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 152 154 152 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 204 208 204 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 208 212 208 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 218 223 218 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 223 227 223 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 236 240 236 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 240 244 240 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 244 249 244 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 249 253 249 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 298 300 298 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 358 360 358 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 435 437 435 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 500 501 500 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 51 56 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 198 202 <span type="species:ncbi:10090">mice</span>
###xml 212 216 <span type="species:ncbi:10090">mice</span>
###xml 227 231 <span type="species:ncbi:10090">mice</span>
###xml 253 257 <span type="species:ncbi:10090">mice</span>
###xml 274 279 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 287 290 <span type="species:ncbi:10298">KOS</span>
###xml 401 405 <span type="species:ncbi:10090">mice</span>
###xml 531 536 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
A subset of neurons synthesize LAT RNAs as soon as HSV-1 infection spreads to the TG [22]. The relative frequency of LAT+ neurons and viral antigen (Ag)+ neurons was compared in the TG of wild-type mice, rag2-/- mice, stat1-/- mice, or rag2-/- stat1-/- mice inoculated with HSV-1 strain KOS (2 x 105 pfu per eye). On days 3 and 5.5 p.i., the frequency of LAT+ neurons was equivalent in all strains of mice, and approximately 1 to 3 LAT+ neurons were observed for every 1000 TG neurons counted (Table 3). Thus, the process by which HSV-1 rapidly establishes latent infections in this subset of neurons is not dependent on lymphocytes (as previously shown; Ref. 22) or the Stat 1 signaling pathway.
###end p 59
###begin p 60
###xml 16 18 16 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 36 38 36 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 82 87 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 95 98 <span type="species:ncbi:10298">KOS</span>
Abundance of LAT+ versus HSV antigen+ neurons in trigeminal ganglia infected with HSV-1 strain KOS.
###end p 60
###begin p 61
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><bold>a</bold></sup>
###xml 33 35 33 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 60 65 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 73 76 <span type="species:ncbi:10298">KOS</span>
###xml 236 241 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
aMice were inoculated with 2 x 105 pfu per eye of wild-type HSV-1 strain KOS, and were sacrificed 72 hours (Day 3) or 132 hours (Day 5.5) after inoculation to measure the relative abundance of trigeminal ganglion neurons that expressed HSV-1 LAT RNA versus viral antigens.
###end p 61
###begin p 62
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><bold>b</bold></sup>
###xml 30 33 <span type="species:ncbi:10298">KOS</span>
bNeurons in 7 muM sections of KOS-infected trigeminal ganglia (TG) that hybridized with a latency-associated transcript (LAT)-specific riboprobe and which were HSV antigen-negative, as determined under a fluorescent microscope.
###end p 62
###begin p 63
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><bold>c</bold></sup>
###xml 30 33 <span type="species:ncbi:10298">KOS</span>
###xml 88 94 <span type="species:ncbi:9986">rabbit</span>
cNeurons in 7 muM sections of KOS-infected trigeminal ganglia (TG) that were labeled by rabbit anti-HSV antibody and which were LAT-negative, as determined under a fluorescent microscope.
###end p 63
###begin p 64
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><bold>d</bold></sup>
###xml 50 51 50 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 67 68 67 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 404 406 404 406 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 420 422 420 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
dThe estimated percent of TG neurons that were LAT+, or HSV antigen+, is based on the total number of neurons counted (number shown in parentheses) in a total of 144 TG sections derived from 6 independent TG (i.e., 24 sections per TG were analyzed). It was estimated that this number of sections contained at least 30,000 neurons but not more than 60,000 neurons. The reported range of percentages of LAT+ or HSV antigen+ neurons was estimated by dividing the number of counted neurons by these lower or upper limits (30,000 or 60,000), and by multiplying times 100 to convert to a percentage.
###end p 64
###begin p 65
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><bold>e</bold></sup>
eTNTC, too numerous to count.
###end p 65
###begin p 66
###xml 34 36 34 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 87 89 87 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 104 105 104 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 146 148 146 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 214 216 214 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 297 299 297 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 343 347 343 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 347 351 347 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 391 392 391 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 418 420 418 420 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 468 473 468 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 473 477 473 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 481 485 481 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 485 489 485 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 489 494 489 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 494 498 494 498 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 351 355 <span type="species:ncbi:10090">mice</span>
###xml 379 383 <span type="species:ncbi:10090">mice</span>
###xml 498 502 <span type="species:ncbi:10090">mice</span>
###xml 683 688 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
During the acute infection, HSV Ag+ neurons were >100-fold more abundant in TG than LAT+ neurons (Table 3). On day 3 p.i., the frequency of HSV Ag+ neurons was equivalent in all groups of TG, and ~100 to 300 HSV Ag+ neurons were observed for every 1000 TG neurons analyzed. On day 5.5 p.i., HSV Ag+ neurons were twice as abundant in the TG of rag2-/- mice relative to strain 129 mice (Table 3). On day 5.5 p.i., HSV Ag+ neurons were too numerous to count in the TG of stat1-/- and rag2-/- stat1-/- mice and viral CPE severely compromised the integrity of the tissue. Thus, consistent with other results, the Stat 1 signaling pathway was essential to restrict the spread of wild-type HSV-1 from the site of inoculation to the TG.
###end p 66
###begin title 67
###xml 7 9 7 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
An ICP0- virus establishes latent infections in the trigeminal ganglia of mice
###end title 67
###begin p 68
###xml 42 44 42 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 108 113 108 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 113 117 113 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 123 128 123 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifngr</italic>
###xml 128 132 128 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 141 146 141 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 146 150 146 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 241 243 241 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 320 325 320 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 325 329 325 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 338 343 338 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifngr</italic>
###xml 343 347 343 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 374 376 374 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 392 393 392 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 405 406 405 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 465 469 465 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 469 473 469 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 473 478 473 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 478 482 478 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 495 500 495 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 500 504 500 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 504 509 504 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifngr</italic>
###xml 509 513 509 513 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 530 535 530 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 535 539 535 539 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 606 608 606 608 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 624 625 624 625 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 637 638 637 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 102 106 <span type="species:ncbi:10090">mice</span>
###xml 117 121 <span type="species:ncbi:10090">mice</span>
###xml 132 136 <span type="species:ncbi:10090">mice</span>
###xml 150 154 <span type="species:ncbi:10090">mice</span>
###xml 181 186 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 194 197 <span type="species:ncbi:10298">KOS</span>
###xml 214 218 <span type="species:ncbi:10090">mice</span>
###xml 258 261 <span type="species:ncbi:10298">KOS</span>
###xml 314 318 <span type="species:ncbi:10090">mice</span>
###xml 329 333 <span type="species:ncbi:10090">mice</span>
###xml 347 351 <span type="species:ncbi:10090">mice</span>
###xml 482 486 <span type="species:ncbi:10090">mice</span>
###xml 513 517 <span type="species:ncbi:10090">mice</span>
###xml 539 543 <span type="species:ncbi:10090">mice</span>
The relative efficiency with which an ICP0- virus establishes latent infection in the TG of wild-type mice, ifnar-/- mice, ifngr-/- mice, or stat1-/- mice was compared to wild-type HSV-1 strain KOS. All strain 129 mice inoculated with 2 x 105 pfu per eye of KOS survived the acute infection, as did all strain 129 mice, ifnar-/- mice, or ifngr-/- mice inoculated with 2 x 105 pfu per eye of 0--GFP (Table 4). Despite a ten-fold reduction in viral inoculum, 100% of rag2-/- ifnar-/- mice, 79% of ifnar-/- ifngr-/- mice, and 50% of stat1-/- mice succumbed to acute infection following inoculation with 2 x 104 pfu per eye of 0--GFP (Table 4).
###end p 68
###begin p 69
###xml 46 48 46 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 32 37 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
Efficiency with which wild-type HSV-1 and ICP0- viruses reactivate from latently infected trigeminal ganglia.
###end p 69
###begin p 70
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
a Virus used to inoculate mice.
###end p 70
###begin p 71
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
bDose of virus in 4 mul viral inoculum applied to each eye (i.e., pfu per eye).
###end p 71
###begin p 72
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 19 23 <span type="species:ncbi:10090">mice</span>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
cThe percentage of mice that survived until Day 38 p.i., when mice were first sacrificed for experiments.
###end p 72
###begin p 73
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">d</sup>
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 14 17 <span type="species:ncbi:10298">KOS</span>
dFrequency of KOS or 0--GFP reactivation in latently infected trigeminal ganglia, as determined by the development of cytopathic effect in monolayers of L7 cells co-cultured with ganglion explants.
###end p 73
###begin p 74
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">e</sup>
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 14 17 <span type="species:ncbi:10298">KOS</span>
eFrequency of KOS or 0--GFP reactivation from latently infected trigeminal ganglia, as determined by the presence of infectious virus in trigeminal ganglion homogenates on day 14 post explant.
###end p 74
###begin p 75
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f</sup>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
fThe average number of viral genomes per TG, as determined by competitive PCR analysis of TG DNA harvested from each treatment group of mice (per the results presented in Figure 8).
###end p 75
###begin p 76
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">h</sup>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
hNot determined because too few mice survived the acute infection.
###end p 76
###begin p 77
###xml 17 18 17 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 116 119 <span type="species:ncbi:10298">KOS</span>
* p < 0.05 that 0--GFP genome loads in latently infected TG were equivalent to wild-type levels of viral genomes in KOS latently-infected TG, based on a two-way t-test.
###end p 77
###begin p 78
###xml 252 254 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 419 421 419 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 426 428 426 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 474 475 474 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 542 544 542 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 681 685 681 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 685 689 685 689 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 689 694 689 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 694 698 694 698 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 704 709 704 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 709 713 709 713 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 713 718 713 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifngr</italic>
###xml 718 722 718 722 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 731 736 731 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 736 740 736 740 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 774 776 774 776 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7 </sup>
###xml 817 819 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 0 5 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 216 221 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 489 493 <span type="species:ncbi:10090">mice</span>
###xml 698 702 <span type="species:ncbi:10090">mice</span>
###xml 722 726 <span type="species:ncbi:10090">mice</span>
###xml 740 744 <span type="species:ncbi:10090">mice</span>
###xml 776 781 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
HSV-1 genome loads per TG were analyzed by competitive PCR amplification of a virion protein 16 (VP16) gene sequence. VP16 PCR products were not amplified from uninfected TG DNA, but were consistently amplified from HSV-1 infected TG DNA samples (Fig. 8A). VP16 PCR products amplified from a VP16 plasmid DNA dilution series defined the relationship between PCR product yield and viral genome copy number per PCR (Fig. 8A and 8B). Viral genome load per TG was evaluated in 0--GFP infected mice that developed encephalitis at day 9 p.i. (Fig. 8A). VP16 PCR product amplification was well outside the quantitative range of the PCR assay, but demonstrated that the TG of encephalitic rag2-/- ifnar-/- mice, ifnar-/- ifngr-/- mice, or stat1-/- mice all possessed in excess of 107 HSV-1 genomes per TG on day 9 p.i. (Fig. 8A).
###end p 78
###begin p 79
###xml 24 25 24 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 0 106 0 106 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Measurement of KOS and 0<sup>-</sup>-GFP viral genome loads in the trigeminal ganglia of HSV-1 latently infected mice</bold>
###xml 108 109 108 109 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 461 465 461 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 465 469 465 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 469 474 469 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 474 478 474 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 484 489 484 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 489 493 489 493 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 493 498 493 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifngr</italic>
###xml 498 502 498 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 511 516 511 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 516 520 516 520 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 547 549 547 549 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 565 566 565 566 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 727 729 727 729 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 766 771 766 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifngr</italic>
###xml 771 775 771 775 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 784 789 784 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 789 793 789 793 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 820 822 820 822 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 838 839 838 839 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 848 853 848 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 853 857 853 857 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 884 886 884 886 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 902 903 902 903 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1029 1030 1029 1030 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 1196 1216 1196 1216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">viral genomes per TG</italic>
###xml 1272 1337 1272 1337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">the ratio of VP16 PCR product yield: competitor PCR product yield</italic>
###xml 1583 1585 1583 1585 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3 </sup>
###xml 1595 1597 1595 1597 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 1619 1621 1619 1621 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 1771 1772 1771 1772 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 1873 1874 1873 1874 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 15 18 <span type="species:ncbi:10298">KOS</span>
###xml 78 83 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 102 106 <span type="species:ncbi:10090">mice</span>
###xml 122 127 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 222 227 <span type="species:ncbi:10090">mouse</span>
###xml 266 270 <span type="species:ncbi:10090">mice</span>
###xml 316 320 <span type="species:ncbi:10090">mice</span>
###xml 380 384 <span type="species:ncbi:10090">mice</span>
###xml 478 482 <span type="species:ncbi:10090">mice</span>
###xml 502 506 <span type="species:ncbi:10090">mice</span>
###xml 520 524 <span type="species:ncbi:10090">mice</span>
###xml 590 594 <span type="species:ncbi:10090">mice</span>
###xml 628 633 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 700 704 <span type="species:ncbi:10090">mice</span>
###xml 744 747 <span type="species:ncbi:10298">KOS</span>
###xml 760 764 <span type="species:ncbi:10090">mice</span>
###xml 775 779 <span type="species:ncbi:10090">mice</span>
###xml 793 797 <span type="species:ncbi:10090">mice</span>
###xml 857 861 <span type="species:ncbi:10090">mice</span>
###xml 1644 1649 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 1784 1789 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 1808 1812 <span type="species:ncbi:10090">mice</span>
###xml 1865 1868 <span type="species:ncbi:10298">KOS</span>
###xml 2045 2049 <span type="species:ncbi:10090">mice</span>
###xml 2073 2076 <span type="species:ncbi:10298">KOS</span>
Measurement of KOS and 0--GFP viral genome loads in the trigeminal ganglia of HSV-1 latently infected mice. A. Dotblot of HSV-1 VP16 PCR products. Each "dot" contains VP16 PCR product amplified from the TG DNA of a single mouse, and the n-values indicate numbers of mice per group. TG harvested from uninfected (UI) mice served as negative controls for the PCR. TG harvested from mice dying of encephalitis (Day 9 p.i.) belonged to one of the following groups: rag2-/- ifnar-/- mice, ifnar-/- ifngr-/- mice, or stat1-/- mice inoculated with 2 x 104 pfu per eye of 0--GFP. TG harvested from mice that were latently infected with HSV-1 (Day 40 p.i.) belonged to one of the following groups: strain 129 mice inoculated with 2 x 105 pfu per eye of KOS; strain 129 mice, ifngr-/- mice, or ifnar-/- mice inoculated with 2 x 105 pfu per eye of 0--GFP; or stat1-/- mice inoculated with 2 x 104 pfu per eye of 0--GFP. The standard curve on the right consists of PCR products amplified from a two-fold dilution series of VP16 plasmid DNA. B. The ratio of yields of VP16 to competitor PCR product yields (competitor dotblot not shown) was used to estimate viral genome copy number per PCR. The logarithm of viral genomes per TG, y, was plotted as a function of the mean logarithm of the ratio of VP16 PCR product yield: competitor PCR product yield, x, amplified from duplicate PCRs of each dilution of VP16 plasmid (error bars indicate the standard deviation between duplicate PCRs). The relationship between viral genome load and PCR product yields was described by the equation, y = 0.2556*x3 + 0.1055*x2 + 1.2079*x + 5.9309 (r2 = 0.99). The number of HSV-1 genomes per TG in each sample was derived from fitting the data shown in panel A to the standard curve shown in panel B. C. Number of HSV-1 genomes per TG in mice that were uninfected or were latently infected with KOS or 0--GFP. The dashed line indicates the lower limit of detection of the PCR assay. Asterisks denote significant differences in viral genome load per TG relative to strain 129 mice latently infected with KOS (p < 0.05, two-way t-test).
###end p 79
###begin p 80
###xml 167 169 167 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8C</xref>
###xml 206 207 206 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 233 238 233 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifngr</italic>
###xml 238 242 238 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 270 271 270 271 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 343 348 343 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 348 352 348 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 380 381 380 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 438 443 438 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 443 447 443 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 495 496 495 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 525 526 525 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 584 586 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8C</xref>
###xml 594 595 594 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 634 635 634 635 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 680 685 680 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 685 689 685 689 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 698 703 698 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 703 707 703 707 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 810 812 810 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 0 5 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 24 28 <span type="species:ncbi:10090">mice</span>
###xml 97 100 <span type="species:ncbi:10298">KOS</span>
###xml 130 134 <span type="species:ncbi:10090">mice</span>
###xml 224 228 <span type="species:ncbi:10090">mice</span>
###xml 242 246 <span type="species:ncbi:10090">mice</span>
###xml 335 338 <span type="species:ncbi:10298">KOS</span>
###xml 352 356 <span type="species:ncbi:10090">mice</span>
###xml 447 451 <span type="species:ncbi:10090">mice</span>
###xml 689 693 <span type="species:ncbi:10090">mice</span>
###xml 707 711 <span type="species:ncbi:10090">mice</span>
###xml 781 784 <span type="species:ncbi:10298">KOS</span>
###xml 799 803 <span type="species:ncbi:10090">mice</span>
HSV-1 latently infected mice were sacrificed at day 40 p.i. to measure viral genome load per TG. KOS-latently infected strain 129 mice contained an average of 3.0 x 105 viral genomes per TG (Fig. 8C; Table 4). In strain 129 mice and ifngr-/- mice, the number of latent 0--GFP genomes per TG was ~40% of the wild-type level achieved by KOS. In ifnar-/- mice, the number of latent 0--GFP genomes per TG was ~115% of the wild-type level. In stat1-/- mice (inoculated with a ten-fold lower dose of 0--GFP), the number of latent 0--GFP genomes per TG was ~60% of the wild-type level (Fig. 8C; Table 4). If one considers the primary data, 0--GFP established latent infections in 50% of ifnar-/- mice and stat1-/- mice that met or exceeded the latent viral genome load per TG achieved by KOS in strain 129 mice (Fig. 8A).
###end p 80
###begin title 81
###xml 7 9 7 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
An ICP0- virus reactivates inefficiently from latently infected trigeminal ganglia
###end title 81
###begin p 82
###xml 42 43 42 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 50 51 50 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 61 62 61 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 495 496 489 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 582 583 576 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 594 595 588 589 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 653 658 647 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifngr</italic>
###xml 658 662 652 656 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 668 673 662 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 673 677 667 671 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 683 688 677 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 688 692 682 686 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 692 697 686 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifngr</italic>
###xml 697 701 691 695 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 710 715 704 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 715 719 709 713 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 814 815 808 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 843 844 837 838 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 873 878 867 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 878 882 872 876 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 909 914 903 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 914 918 908 912 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 963 964 957 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 984 985 978 979 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1069 1070 1063 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 1147 1149 1141 1143 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 1203 1208 1197 1202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 1208 1212 1202 1206 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1224 1225 1218 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 1232 1234 1226 1228 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 1332 1334 1326 1328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1335 1337 1329 1331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 33 36 <span type="species:ncbi:10298">KOS</span>
###xml 130 134 <span type="species:ncbi:10090">mice</span>
###xml 348 351 <span type="species:ncbi:10298">KOS</span>
###xml 399 403 <span type="species:ncbi:10090">mice</span>
###xml 548 551 <span type="species:ncbi:10298">KOS</span>
###xml 647 651 <span type="species:ncbi:10090">mice</span>
###xml 662 666 <span type="species:ncbi:10090">mice</span>
###xml 677 681 <span type="species:ncbi:10090">mice</span>
###xml 701 705 <span type="species:ncbi:10090">mice</span>
###xml 719 723 <span type="species:ncbi:10090">mice</span>
###xml 1133 1138 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 1212 1216 <span type="species:ncbi:10090">mice</span>
The efficiency with which latent KOS (ICP0+) and 0--GFP (ICP0-) reactivated from TG explants was compared. TG were harvested from mice on days 38 and 39 p.i., heat stressed at 43degreesC for 3 hours, co-cultured with L7 cell monolayers for 14 days, and were homogenized on day 14 to test for the presence of infectious virus within each TG. Of the KOS-latently infected TG harvested from strain 129 mice, 11 of 16 TG explants produced infectious virus that spread to co-cultured L7 cells (Table 4), and 14 of 16 TG homogenates contained infectious KOS on day 14 post explant (Table 4). Of the 0--GFP-latently infected TG harvested from strain 129 mice, ifngr-/- mice, ifnar-/- mice, ifnar-/- ifngr-/- mice, or stat1-/- mice, 0 of 98 TG explants produced infectious virus that spread to co-cultured L7 cells (Table 4). In contrast, infectious 0--GFP was detected in 2 of 16 ifnar-/- TG homogenates and 2 of 22 stat1-/- TG homogenates on day 14 post explant (Table 4). Reactivation of 0--GFP was detected in none of the other TG homogenates on day 14 post explant (Table 4). Thus, consistent with previous results, even when wild-type HSV-1 and ICP0- viruses establish equivalent latent infections (e.g., ifnar-/- mice; Table 4), ICP0- viruses are severely impaired in their capacity to reactivate from latently infected TG explants [23,24].
###end p 82
###begin title 83
###xml 38 40 38 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 82 87 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
Prior infection with an avirulent ICP0- virus induces protective immunity against HSV-1
###end title 83
###begin p 84
###xml 25 27 25 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 150 152 150 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 165 167 165 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 289 291 289 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 307 308 307 308 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 323 325 323 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 340 342 340 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 387 388 387 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 475 477 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9A</xref>
###xml 492 494 492 494 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 526 528 526 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9B</xref>
###xml 556 557 556 557 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 570 572 570 572 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 645 651 645 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9A, 9B</xref>
###xml 708 710 708 710 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 750 751 750 751 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 853 855 853 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9A</xref>
###xml 870 871 870 871 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 999 1001 999 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9A</xref>
###xml 1011 1013 1011 1013 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 1155 1157 1153 1155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9B</xref>
###xml 216 221 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 257 261 <span type="species:ncbi:10090">mice</span>
###xml 587 591 <span type="species:ncbi:10090">mice</span>
###xml 676 680 <span type="species:ncbi:10090">mice</span>
###xml 725 730 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 776 780 <span type="species:ncbi:10090">mice</span>
###xml 793 797 <span type="species:ncbi:10090">mice</span>
###xml 885 889 <span type="species:ncbi:10090">mice</span>
###xml 1028 1032 <span type="species:ncbi:10090">mice</span>
###xml 1082 1086 <span type="species:ncbi:10090">mice</span>
Interferon-sensitive ICP0- viruses have not been considered for their potential to vaccinate against herpetic disease. The efficacy with which an ICP0- virus or ICP4- virus induced protective immunity against lethal HSV-1 challenge was compared. Strain 129 mice were inoculated with 2 x 105 pfu per eye of 0--GFP or an ICP4- virus. The ICP0- virus replicated transiently, but titers of 0--GFP in ocular tear film remained low to undetectable between days 3 and 30 p.i. (Fig. 9A), and the ICP4- virus failed to replicate (Fig. 9B). As anticipated, 100% of 0--GFP- or ICP4- virus-infected mice survived and remained healthy for 30 days p.i. (Fig. 9A, 9B). On day 30 p.i., these mice were challenged with 2 x 105 pfu per eye of HSV-1 strain McKrae. In 0--GFP-infected strain 129 mice, one of six mice shed detectable virus at 24 hours post-challenge (Fig. 9A). All of the 0--GFP-infected mice remained healthy until the conclusion of the experiment, 30 days after secondary challenge with McKrae (Fig. 9A). In ICP4- virus-infected mice, McKrae replicated to high titers in the eyes of mice, and progressed to fatal encephalitis within 5.8 +/- 0.2 days (Fig. 9B).
###end p 84
###begin p 85
###xml 7 9 7 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 0 65 0 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink">An ICP0<sup>- </sup>virus induces a protective immune response against HSV-1</bold>
###xml 110 112 110 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 131 132 131 132 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 138 140 138 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 147 148 147 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 156 157 156 157 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 167 169 167 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 203 207 203 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag2</italic>
###xml 207 211 207 211 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 243 245 243 245 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 264 265 264 265 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 271 273 271 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 280 281 280 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 289 290 289 290 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 300 302 300 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 467 468 465 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 495 497 493 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 570 571 568 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 593 595 591 593 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 654 656 652 654 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 751 755 749 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 755 759 753 757 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 60 65 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 186 190 <span type="species:ncbi:10090">mice</span>
###xml 211 215 <span type="species:ncbi:10090">mice</span>
###xml 319 323 <span type="species:ncbi:10090">mice</span>
###xml 401 406 <span type="species:ncbi:10090">mouse</span>
###xml 482 486 <span type="species:ncbi:10090">mice</span>
###xml 512 516 <span type="species:ncbi:10090">mice</span>
###xml 610 614 <span type="species:ncbi:10090">mice</span>
###xml 671 676 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 743 747 <span type="species:ncbi:10090">mice</span>
###xml 759 763 <span type="species:ncbi:10090">mice</span>
An ICP0- virus induces a protective immune response against HSV-1. Strain 129 mice were inoculated with 2 x 105 pfu per eye of the A. ICP0- virus 0--GFP or B. the ICP4- virus n12 (n = 6 mice per group). Rag2-/- mice were inoculated with 2 x 105 pfu per eye of the C. ICP0- virus 0--GFP or D. the ICP4- virus n12 (n = 6 mice per group). The mean +/- sem of the logarithm of viral titers recovered from mouse eyes is plotted over time (black symbols). The survival of 0--GFP-infected mice and ICP4- virus-infected mice is plotted over time (red symbols). On day 30 p.i., 0--GFP-infected and ICP4- virus-infected mice were secondarily challenged with 2 x 105 pfu per eye of HSV-1 strain McKrae. Viral titers recovered from the eyes of strain 129 mice or rag2-/- mice after secondary challenge with McKrae is plotted over time (blue symbols). Dashed lines indicate the lower limit of detection of the plaque assay.
###end p 85
###begin p 86
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 21 25 21 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 79 83 79 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 83 87 83 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 98 99 98 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 115 117 115 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9C</xref>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9D</xref>
###xml 268 272 268 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 272 276 272 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 358 362 358 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 362 366 362 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 404 405 404 405 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 421 423 421 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 435 437 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9C</xref>
###xml 442 444 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9D</xref>
###xml 454 456 454 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 471 475 471 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 475 479 475 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 576 578 574 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9D</xref>
###xml 585 586 583 584 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 600 604 598 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 604 608 602 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 692 694 688 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9C</xref>
###xml 745 746 741 742 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 848 849 844 845 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 880 884 876 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 884 888 880 884 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 895 896 891 892 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 25 29 <span type="species:ncbi:10090">mice</span>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
###xml 202 206 <span type="species:ncbi:10090">mice</span>
###xml 276 280 <span type="species:ncbi:10090">mice</span>
###xml 366 370 <span type="species:ncbi:10090">mice</span>
###xml 479 483 <span type="species:ncbi:10090">mice</span>
###xml 608 612 <span type="species:ncbi:10090">mice</span>
###xml 888 892 <span type="species:ncbi:10090">mice</span>
###xml 943 948 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
Equal numbers of rag2-/- mice were included in this experiment. Inoculation of rag2-/- mice with 0--GFP or the ICP4- virus produced an equivalent pattern of viral shedding as was observed in strain 129 mice between days 1 and 30 p.i. (Fig. 9C and 9D). On day 30 p.i., rag2-/- mice were secondarily challenged with McKrae. McKrae replicated to high titers in rag2-/- mice that were first inoculated with 0--GFP or the ICP4- virus (Fig. 9C and 9D). In ICP4- virus-infected rag2-/- mice, McKrae infection progressed to fatal encephalitis by 5.7 +/- 0.1 days post challenge (Fig. 9D). In 0--GFP-infected rag2-/- mice, McKrae infection required 9.0 +/- 0.5 days to progress to fatal disease (Fig. 9C), suggesting that the ongoing innate response to 0--GFP infection delayed the progression of McKrae infection to a fatal encephalitis. Therefore, while 0--GFP infection is avirulent in rag2-/- mice, 0--GFP cannot induce protective immunity against HSV-1 in animals that lack a lymphocyte-driven adaptive immune response.
###end p 86
###begin title 87
Discussion
###end title 87
###begin title 88
###xml 64 69 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
IFN receptors and Stat 1 are integral to innate host control of HSV-1 infection
###end title 88
###begin p 89
###xml 36 41 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 41 45 34 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 140 145 133 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 145 149 138 142 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 176 181 169 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 181 185 174 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 247 252 240 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 252 256 245 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 268 269 261 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 282 287 275 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 287 291 280 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 319 321 312 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 365 366 358 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 384 389 377 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 389 393 382 386 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 407 408 400 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 487 491 480 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 491 495 484 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 512 513 505 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 604 605 590 591 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 649 653 635 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 653 657 639 643 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 657 662 643 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 662 666 648 652 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 675 679 661 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 679 683 665 669 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 683 688 669 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 688 692 674 678 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 740 744 719 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">and </italic>
###xml 740 744 719 723 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>and </italic></bold>
###xml 819 821 794 796 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 922 927 897 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 927 931 902 906 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1072 1079 1036 1043 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 45 49 <span type="species:ncbi:10090">mice</span>
###xml 83 88 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 149 153 <span type="species:ncbi:10090">mice</span>
###xml 185 189 <span type="species:ncbi:10090">mice</span>
###xml 256 260 <span type="species:ncbi:10090">mice</span>
###xml 291 295 <span type="species:ncbi:10090">mice</span>
###xml 393 397 <span type="species:ncbi:10090">mice</span>
###xml 495 499 <span type="species:ncbi:10090">mice</span>
###xml 666 670 <span type="species:ncbi:10090">mice</span>
###xml 692 696 <span type="species:ncbi:10090">mice</span>
###xml 698 702 <span type="species:ncbi:10090">Mice</span>
###xml 931 935 <span type="species:ncbi:10090">mice</span>
###xml 1059 1064 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
Loss of IFN-alpha/beta receptors in ifnar-/- mice compromised innate resistance to HSV-1, but the defect was not as profound as observed in stat1-/- mice. Thus, on day 3 p.i., ifnar-/- mice shed 30- to 100-times less infectious virus per eye than stat1-/- mice (Table 2). Likewise, ifnar-/- mice uniformly survived ICP0- viral infections with little disease (Table 2), whereas 50% of stat1-/- mice died of 0--GFP infection and all of the survivors were frankly diseased. The capacity of rag2-/- mice to repress 0--GFP replication was clearly dependent on the IFN-alpha/beta receptor and Stat 1, because 0--GFP produced uniformly fatal infections in rag2-/- ifnar-/- mice and rag2-/- stat1-/- mice. Mice that lacked IFN-alpha/beta receptors and IFN-gamma receptors failed to suppress the replication of wild-type or ICP0- viruses at the site of inoculation. Because the extent of the defect was similar to that observed in stat1-/- mice, the combined activities of IFN-alpha/beta and IFN-gamma appear to activate the Stat 1-dependent host response that limits HSV-1 spread in vivo.
###end p 89
###begin p 90
###xml 206 207 199 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 363 368 356 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 368 372 361 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 372 377 365 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifngr</italic>
###xml 377 381 370 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 424 426 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 514 516 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 594 599 587 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 599 603 592 596 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 732 737 725 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 737 741 730 734 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 741 746 734 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifngr</italic>
###xml 746 750 739 743 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 759 764 752 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 764 768 757 761 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1254 1256 1236 1238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1257 1259 1239 1241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1330 1335 1312 1317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 1335 1339 1317 1321 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1339 1344 1321 1326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifngr</italic>
###xml 1344 1348 1326 1330 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 50 55 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 319 324 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 381 385 <span type="species:ncbi:10090">mice</span>
###xml 463 468 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 506 512 <span type="species:ncbi:9606">humans</span>
###xml 603 607 <span type="species:ncbi:10090">mice</span>
###xml 632 637 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 750 754 <span type="species:ncbi:10090">mice</span>
###xml 768 772 <span type="species:ncbi:10090">mice</span>
###xml 835 839 <span type="species:ncbi:10090">mice</span>
###xml 1139 1144 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 1315 1320 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 1348 1352 <span type="species:ncbi:10090">mice</span>
###xml 1380 1385 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 1456 1461 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
The innate resistance of host structural cells to HSV-1 appears to be compromised in the absence of Stat 1 or IFN-alpha/beta receptors, presumably because these cells fail to mount an antiviral state (Fig. 7). However, this simple explanation does not account for all of the observations presented herein. For example, HSV-1 produced a rapid and fatal disease in ifnar-/- ifngr-/- mice, which as described by Luker, et al. [19], appeared to be a viral hepatitis. HSV-1 infection rarely causes hepatitis in humans [25], and liver infection is not a prominent feature in animal models. Moreover, stat1-/- mice infected with wild-type HSV-1 died of encephalitis two to three days later. This divergence in the outcomes of infection in ifnar-/- ifngr-/- mice and stat1-/- mice draws attention to an important caveat of studies in knockout mice: despite the targeted nature of the genetic mutations, loss of a single protein may have pleiotropic effects. For example, basic immune functions such as hematopoiesis or leukocyte activation may be altered by combinations of these mutations. Alternatively, the non-permissiveness of leukocytes for HSV-1 replication may be dependent on the combined activities of IFN-alpha/beta receptors and IFN-gamma receptors [26,27]. Thus, the fulminant liver infection that develops in HSV-1-infected ifnar-/- ifngr-/- mice may be due to uncontrolled HSV-1 replication in at least one leukocyte subset, which would confer upon HSV-1 the unusual property of blood-borne spread to the liver. Given such possibilities, the results of the current study must be interpreted with a certain degree of caution.
###end p 90
###begin title 91
###xml 51 56 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
Stat 1 is not essential for the early synthesis of HSV-1 latency-associated transcripts
###end title 91
###begin p 92
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 165 167 165 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 178 183 178 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 183 187 183 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 194 199 194 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 199 203 199 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 270 271 270 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 382 387 382 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 387 391 387 391 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 411 413 411 413 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 443 444 443 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 459 461 459 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 495 500 495 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 500 504 500 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 516 518 516 518 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 597 598 597 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 618 623 618 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 623 627 623 627 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 631 635 631 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 635 639 635 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 639 644 639 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 644 648 644 648 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 907 925 907 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink">entire population </italic>
###xml 67 72 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 203 207 <span type="species:ncbi:10090">mice</span>
###xml 322 327 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 504 508 <span type="species:ncbi:10090">mice</span>
###xml 648 652 <span type="species:ncbi:10090">mice</span>
###xml 1013 1018 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 1134 1139 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
A subset of neurons express LAT RNAs, but not viral proteins, when HSV-1 first enters the TG on day 3 after ocular inoculation [22]. Comparison of the numbers of LAT+ neurons in stat1+/+ versus stat1-/- mice indicated that this phenomenon is not Stat 1-dependent (Table 3). Thus, the Checkpoint Model fails to explain how HSV-1 establishes latent infections in the subpopulation of stat1-/- neurons that are LAT+ on days 3 and 5.5 p.i. (Table 3). Although LAT+ neurons were certainly present in stat1-/- mice, HSV Ag+ neurons were 100- to 500-fold more abundant between days 3 and 5.5 p.i. (Table 3). On day 5.5 p.i., stat1-/- and rag2-/- stat1-/- mice were diseased, their TG were beginning to hemorrhage, and the animals were within 24 hours of death. Clinically, herpesviral latency refers to the absence of infectious virus and disease in a host, and requires the repression of viral replication in the entire population of virus-infected cells in the body. Thus, although a small subset of neurons represses HSV-1 replication in a Stat 1-independent manner, we conclude that both Stat 1 and lymphocytes are required for a latent HSV-1 infection to be established at the clinically relevant level of the host organism.
###end p 92
###begin title 93
ICP0 antagonizes Stat 1-dependent repression of herpes simplex virus
###end title 93
###begin p 94
###xml 4 6 4 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scid </italic>
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 51 55 51 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 80 82 80 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 265 267 265 267 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 287 289 287 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 364 369 364 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scid </italic>
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 378 380 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 535 537 528 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 548 553 541 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scid </italic>
###xml 556 560 549 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 560 564 553 557 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
###xml 234 239 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 300 305 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 369 373 <span type="species:ncbi:10090">mice</span>
###xml 564 568 <span type="species:ncbi:10090">mice</span>
ICP0- viruses are rapidly repressed in scid or rag2-/- mice. The failure of ICP0- viruses to sustain replication in lymphocyte-deficient mice is not due to a leaky adaptive immune response, nor is this a non-specific phenotype of any HSV-1 mutant. For example, VP16- and thymidine kinase- mutants of HSV-1 establish slowly progressing infections that are fatal in scid mice [28,29]. Rather, it appears that an innate host response that is dependent upon the IFN-alpha/beta receptor and Stat 1 potently represses the replication of ICP0- viruses in scid or rag2-/- mice.
###end p 94
###begin p 95
###xml 191 200 191 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 201 202 201 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 203 204 203 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 466 490 466 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">when ICP0 is synthesized</italic>
###xml 616 644 616 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">when ICP0 is not synthesized</italic>
###xml 84 89 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 173 178 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 345 350 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 554 559 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 696 701 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
It is generally believed that ICP0 functions as an activator in the balance between HSV-1 latency and reactivation, and that ICP0 acts to prevent host cells from repressing HSV-1 replication in vitro [5,6,30]. However, a credible explanation has been lacking to explain how synthesis of ICP0, or lack thereof, can globally effect whether or not HSV-1 initiates productive viral replication. The results of the current study suggest a potentially simple explanation: when ICP0 is synthesized, the protein overcomes Stat 1-dependent cellular repression of HSV-1 such that the virus can complete its replication cycle; when ICP0 is not synthesized, Stat 1-dependent cellular repression silences the HSV-1 genome.
###end p 95
###begin p 96
###xml 60 69 60 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 70 71 70 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 72 74 72 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 75 77 75 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 78 80 78 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 302 304 302 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 334 337 334 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PML</italic>
###xml 337 341 337 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 430 432 430 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 440 447 440 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 341 345 <span type="species:ncbi:10090">mice</span>
###xml 540 545 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
Given ICP0's capacity to function as a viral IFN antagonist in vitro [9,10,14,15], we infer that ICP0 most likely functions in virus-infected cells to prevent an IFN-inducible block to viral replication (Checkpoint 1, Fig. 1C). Although PML has been proposed to serve a critical role in repressing ICP0- viruses [21], our findings in PML-/- mice do not support a direct role for PML in the process by which host cells repress ICP0- viruses in vivo. Therefore, it remains to be determined how ICP0 antagonizes Stat 1-dependent repression of HSV-1.
###end p 96
###begin title 97
Implications for the regulation of viral latency
###end title 97
###begin p 98
###xml 49 51 49 51 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 144 145 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 201 202 201 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 201 202 201 202 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1</italic></bold>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 286 288 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 291 292 291 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2</italic>
###xml 291 292 291 292 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>2</italic></bold>
###xml 438 440 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 441 443 441 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 446 447 446 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3</italic>
###xml 446 447 446 447 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>3</italic></bold>
###xml 539 541 539 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 542 544 542 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 551 552 551 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">4</italic>
###xml 551 552 551 552 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>4</italic></bold>
###xml 733 734 733 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 124 129 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 231 236 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 487 492 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 607 612 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
The available evidence suggests that the 9.3 kb RL region, which contains the ICP0 gene, plays a pivotal role in regulating HSV-1 latency (Fig. 4). The evidence that supports this point is summarized: 1. Synthesis of ICP0 promotes HSV-1 reactivation in latently infected TG neurons [24,31]; 2. The antisense LAT gene is the only viral gene transcribed during latency and produces stable 1.5 and 2.0 kb introns that accumulate in neurons [32,33]; 3. Synthesis of ICP34.5 is necessary for HSV-1 to complete its replication cycle in neurons [34-36]; and 4. De-repression of the antisense L/ST gene produces an HSV-1 mutant that overexpresses L/ST RNA and is replication-impaired in neurons despite an intact ICP34.5 open-reading frame [3].
###end p 98
###begin p 99
###xml 27 28 27 28 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 149 157 149 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 356 361 356 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scid </italic>
###xml 367 369 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 442 444 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 522 529 515 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 733 740 726 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 110 115 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 203 208 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 308 313 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 361 365 <span type="species:ncbi:10090">mice</span>
###xml 504 509 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 587 592 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 686 691 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
Failure to synthesize the RL-encoded viral IFN antagonists, ICP0 or ICP34.5, is a possible mechanism by which HSV-1 may cease productive replication in vivo (Fig. 1C). Failure to synthesize ICP0 renders HSV-1 vulnerable to repression by the host IFN response. Likewise, failure to synthesize ICP34.5 renders HSV-1 vulnerable to innate immune repression in scid mice [37], and this repression is dependent on IFN-alpha/beta receptors and PKR [11]. If synthesis of ICP0 and ICP34.5 is necessary to promote HSV-1 replication in vivo, then it is possible that the LAT and L/ST genes provide HSV-1 with an efficient mechanism to pro-actively halt the synthesis of ICP0 or ICP34.5, such that HSV-1 can rapidly cease productive replication in vivo.
###end p 99
###begin p 100
###xml 253 254 253 254 <bold xmlns:xlink="http://www.w3.org/1999/xlink">1</bold>
###xml 301 303 301 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 315 316 315 316 <bold xmlns:xlink="http://www.w3.org/1999/xlink">2</bold>
###xml 365 367 365 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 441 443 441 443 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 456 457 456 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 724 725 724 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 724 725 724 725 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>i</italic></bold>
###xml 862 864 862 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 867 869 867 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ii</italic>
###xml 867 869 867 869 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>ii</italic></bold>
###xml 938 940 938 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 941 943 941 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 950 953 950 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink">iii</italic>
###xml 950 953 950 953 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>iii</italic></bold>
###xml 984 986 984 986 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 1071 1073 1071 1073 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1082 1084 1082 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1085 1087 1085 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 53 58 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 548 553 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 654 659 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 838 843 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 875 880 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
This hypothesis may seem counterintuitive. Why would HSV-1 carry two genes that promote the IFN-induced repression of the viral genome? Therefore, it is worth noting that herpesviruses are presented with two choices at the height of an immune response: 1. cytolytic destruction of the host cell by CD8+ T cells, or 2. cessation of viral antigen synthesis before CD8+ T cells can destroy the host cell. Given the arrangement of genes in the RL region (Fig. 4), it is possible that the LAT and/or L/ST genes may serve to ensure the timely shutoff of HSV-1 replication and antigen synthesis when the local immune response exceeds a critical threshold in an HSV-1 infected tissue. This hypothesis may be relevant in explaining: i. how viral antigen synthesis decreases from high to undetectable levels within 8 hours after T cells infiltrate HSV-1 infected ganglia [38]; ii. how HSV-1 infected neurons avoid cytolytic destruction by T cells [39,40]; and iii. why neurons infected with LAT- viruses undergo apoptosis (cytolysis?) more frequently than neurons infected with LAT+ viruses [41-43]. Given the dearth of evidence that the LAT or L/ST genes actually antagonize the synthesis of ICP0 and ICP34.5, further work will be required to address these hypotheses.
###end p 100
###begin title 101
Clinical implications
###end title 101
###begin p 102
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 304 306 304 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 373 378 373 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scid </italic>
###xml 381 385 381 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 385 389 385 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 425 427 425 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 523 524 523 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 629 630 629 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
###xml 674 676 674 676 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 0 5 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 136 141 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 389 393 <span type="species:ncbi:10090">mice</span>
###xml 595 599 <span type="species:ncbi:10090">mice</span>
###xml 617 622 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
HSV-1 becomes hypersensitive to IFN-inducible repression in the absence of ICP0 or ICP34.5 [16]. Given the extensive similarity between HSV-1 and HSV-2, the results suggest a logical approach to develop a live, attenuated vaccine against genital herpes. When introduced at the peripheral epithelium, ICP0- viruses are incapable of producing disease in lymphocyte-deficient scid or rag2-/- mice. Despite their avirulence, ICP0- viruses establish latent infections in the ganglia that innervate the site of inoculation (Fig. 8) and elicit an adaptive immune response that protects immunocompetent mice against virulent HSV-1 (Fig. 9). In contrast, a replication-defective ICP4- virus fails to elicit any semblance of protective immunity.
###end p 102
###begin p 103
###xml 67 68 67 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink">1</bold>
###xml 215 216 215 216 <bold xmlns:xlink="http://www.w3.org/1999/xlink">2</bold>
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 391 393 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 575 577 575 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 578 580 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 773 775 773 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 776 778 776 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 984 986 984 986 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 797 803 <span type="species:ncbi:9606">people</span>
###xml 828 833 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
The advantage of a live, attenuated HSV vaccine would be two-fold: 1. the vaccine strain would be antigenically identical to wild-type HSV with the exception of a single mutated open-reading frame (e.g., ICP0), and 2. the latent infection established by such a virus might boost the adaptive immune response over time through periodic synthesis of viral antigen at the single cell level [44,45]. Failure to sustain a broad-based immune response over time likely accounts for the failure of subunit vaccines or replication-defective viruses to protect against genital herpes [46,47]. While a live HSV vaccine is often considered unsafe because the vaccine strain would establish a latent infection in the recipient, such claims ignore the natural history of HSV infections [48,49]. About 4 billion people currently harbor latent HSV-1 and/or HSV-2 in their nervous system, and ~3 billion of these infections are asymptomatic. Further investigation will be required to determine if ICP0- strains of HSV-2 can be used to achieve an appropriate balance between safety and antigenicity in developing a live, attenuated vaccine against genital herpes.
###end p 103
###begin title 104
Conclusion
###end title 104
###begin p 105
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 174 176 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 129 134 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 340 345 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
In recent years, it has become increasingly evident that the host immune response plays a more direct role in the maintenance of HSV-1 latency than previously envisioned [50,51]. The results of the current study add to this body of evidence, and suggest that the antagonistic actions of host IFNs and the viral IFN antagonist ICP0 may help HSV-1 "choose" between one of its two programs of gene expression, productive replication or latent infection. The proposed Checkpoint Model (Fig. 1C) represents an initial attempt to explain these observations, and will require extensive testing to determine its validity.
###end p 105
###begin p 106
###xml 492 500 492 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 163 168 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
Despite its limitations, the Checkpoint Model offers a useful conceptual framework from which to begin considering whether these observations are really unique to HSV-1. Most persistent viruses possess the capacity to alternate between rapid, slow, and/or non-existent modes of productive replication. Therefore, it is worth considering that perhaps other persistent viruses also encode "activators" such as ICP0 whose synthesis (or lack thereof) regulates the rate of productive replication in vivo by virtue of antagonizing a host repressor that has been present since the dawn of life: the innate host response to viral infections.
###end p 106
###begin title 107
Methods
###end title 107
###begin title 108
Cells and viruses
###end title 108
###begin p 109
###xml 25 27 25 27 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 110 111 110 111 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 111 113 111 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 371 373 371 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 385 387 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 421 424 421 424 <underline xmlns:xlink="http://www.w3.org/1999/xlink">TAG</underline>
###xml 426 429 426 429 <underline xmlns:xlink="http://www.w3.org/1999/xlink">TAG</underline>
###xml 431 434 431 434 <underline xmlns:xlink="http://www.w3.org/1999/xlink">TAG</underline>
###xml 586 587 586 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 604 605 604 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 672 674 672 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 685 687 685 687 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 728 731 728 731 <underline xmlns:xlink="http://www.w3.org/1999/xlink">TAG</underline>
###xml 732 735 732 735 <underline xmlns:xlink="http://www.w3.org/1999/xlink">TAA</underline>
###xml 736 739 736 739 <underline xmlns:xlink="http://www.w3.org/1999/xlink">TAG</underline>
###xml 901 902 901 902 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 950 952 950 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 140 146 <span type="species:ncbi:9913">bovine</span>
###xml 267 272 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 281 284 <span type="species:ncbi:10298">KOS</span>
###xml 286 289 <span type="species:ncbi:10298">KOS</span>
###xml 469 474 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 482 485 <span type="species:ncbi:10298">KOS</span>
###xml 776 781 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 789 792 <span type="species:ncbi:10298">KOS</span>
Vero cells and L7 cells [52] were propagated in Dulbecco's Modified Eagle's medium (DMEM) containing 0.15% HCO3- supplemented with 5% fetal bovine serum (FBS), penicillin G (100 U/ml), and streptomycin (100 mg/ml), hereafter referred to as "complete DMEM." Wild-type HSV-1 strains KOS, KOS-GFP, and McKrae were propagated in Vero cells cultured in complete DMEM. The ICP0- virus n212 [53,54] contains a 14 bp insertion (CTAGACTAGTCTAG) in codon 212 of the ICP0 gene of HSV-1 strain KOS, which inserts stop codons into all three open-reading frames of the ICP0-encoding DNA strand (Fig. 4). The n212 (ICP0-) virus was propagated and titered in ICP0-complementing L7 cells [52]. The ICP4- virus n12 contains a 16 bp insertion (GGCTAGTTAACTAGCC) in codon 262 of the ICP4 gene of HSV-1 strain KOS, which inserts stop codons into all three open-reading frames of the ICP4-encoding DNA strand. The n12 (ICP4-) virus was propagated and titered in E5 cells [55] (generously provided by Priscilla Schaffer, Harvard University).
###end p 109
###begin p 110
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 0 3 <span type="species:ncbi:10298">KOS</span>
###xml 44 49 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 57 60 <span type="species:ncbi:10298">KOS</span>
###xml 115 118 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 431 434 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 574 579 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
KOS-GFP is a recombinant virus derived from HSV-1 strain KOS that expresses green fluorescent protein (GFP) from a CMV promoter-GFP gene cassette inserted in the intergenic region at the 3' ends of the UL26 and UL27 genes, which converge from opposite strands of DNA [56]. To avoid disrupting the 3' untranslated region of either the UL26 or UL27 gene, the intergenic region (Kpn I - Fsp I; 52,733 - 53,150) was duplicated and the CMV-GFP cassette is inserted between these duplicated sequences. No known open-reading frames are disrupted by this 2.0 kbp insertion into the HSV-1 genome.
###end p 110
###begin p 111
###xml 8 10 8 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 17 18 17 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 190 191 190 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 317 318 317 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 377 379 377 379 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 392 393 392 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 435 436 435 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 557 558 557 558 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 619 621 619 621 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 638 640 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 641 643 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 683 684 683 684 <bold xmlns:xlink="http://www.w3.org/1999/xlink">1</bold>
###xml 701 702 701 702 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 748 752 748 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 752 756 752 756 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 762 763 762 763 <bold xmlns:xlink="http://www.w3.org/1999/xlink">2</bold>
###xml 780 781 780 781 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 802 807 802 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 807 811 807 811 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 817 818 817 818 <bold xmlns:xlink="http://www.w3.org/1999/xlink">3</bold>
###xml 835 836 835 836 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 878 887 871 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 888 890 881 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 893 894 886 887 <bold xmlns:xlink="http://www.w3.org/1999/xlink">4</bold>
###xml 917 918 910 911 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 959 961 952 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 962 964 955 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 967 968 960 961 <bold xmlns:xlink="http://www.w3.org/1999/xlink">5</bold>
###xml 1007 1016 1000 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in trans </italic>
###xml 1056 1057 1049 1050 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1105 1107 1098 1100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1205 1207 1198 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1208 1210 1201 1203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1211 1213 1204 1206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 229 234 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 242 245 <span type="species:ncbi:10298">KOS</span>
###xml 551 554 <span type="species:ncbi:10298">KOS</span>
###xml 756 760 <span type="species:ncbi:10090">mice</span>
###xml 811 815 <span type="species:ncbi:10090">mice</span>
The ICP0- virus 0--GFP was constructed from a chimeric ICP0-GFP gene [57], in which the GFP open-reading frame was inserted into a Xho I restriction site in codon 105 of the ICP0 gene (Fig. 4). This mutation was transferred into HSV-1 strain KOS by homologous recombination. Southern blot analysis demonstrated that 0--GFP possessed the desired mutation in both copies of the RL region (Fig. 4). Northern blot analysis confirmed that 0--GFP expresses an ICP0 mRNA that migrates at ~3.1 kb as opposed to the wild-type 2.4 kb ICP0 mRNA transcribed from KOS. 0--GFP is phenotypically identical to the well-established ICP0- null virus n212 [53,54], based on the following observations: 1. Both n212 and 0--GFP are repressed with identical kinetics in rag2-/- mice; 2. Both n212 and 0--GFP are virulent in stat1-/- mice; 3. Both n212 and 0--GFP are hypersensitive to IFN-alpha/beta in vitro [14]; 4. Only 1% of n212 and 0--GFP virions form plaques on Vero cells [54,58]; 5. ICP0, but not ICP4 or VP16, provided in trans from adenovirus vectors allow n212 and 0--GFP to efficiently form plaques on Vero cells [31], and the efficiency of plaque formation is the same as observed on ICP0-complementing L7 cells [14,31,52].
###end p 111
###begin title 112
###xml 0 5 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 19 23 <span type="species:ncbi:10090">mice</span>
HSV-1 infection of mice
###end title 112
###begin p 113
###xml 46 47 46 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 140 192 140 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NIH Guide for the Care and Use of Laboratory Animals</italic>
###xml 214 219 214 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scid </italic>
###xml 254 259 250 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifngr</italic>
###xml 259 262 255 258 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 346 350 342 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 350 354 346 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 360 365 356 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 365 369 361 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 379 383 375 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 383 387 379 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 387 392 383 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 392 396 388 392 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 455 459 451 455 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 564 569 553 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 569 572 558 561 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 583 588 572 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 588 592 577 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 592 597 581 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifngr</italic>
###xml 597 601 586 590 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 680 684 669 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag2</italic>
###xml 684 688 673 677 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 688 693 677 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 693 697 682 686 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1044 1046 1032 1034 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 7 11 <span type="species:ncbi:10090">mice</span>
###xml 69 74 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 201 205 <span type="species:ncbi:10090">mice</span>
###xml 219 223 <span type="species:ncbi:10090">mice</span>
###xml 264 268 <span type="species:ncbi:10090">mice</span>
###xml 340 344 <span type="species:ncbi:10090">mice</span>
###xml 354 358 <span type="species:ncbi:10090">mice</span>
###xml 369 373 <span type="species:ncbi:10090">mice</span>
###xml 396 400 <span type="species:ncbi:10090">mice</span>
###xml 459 463 <span type="species:ncbi:10090">mice</span>
###xml 574 578 <span type="species:ncbi:10090">mice</span>
###xml 601 605 <span type="species:ncbi:10090">mice</span>
###xml 697 701 <span type="species:ncbi:10090">mice</span>
###xml 829 833 <span type="species:ncbi:10090">mice</span>
###xml 923 927 <span type="species:ncbi:10090">Mice</span>
Female mice of the strains specified in Table 1 were inoculated with HSV-1 at 6- to 10-weeks of age and were handled in accordance with the NIH Guide for the Care and Use of Laboratory Animals. BALB/c mice, BALB/c scid mice, and IFN-gamma receptor null (ifngr-/-) mice were obtained from the Jackson Laboratory (Bar Harbor, ME). Strain 129 mice, rag2-/- mice, stat1-/- mice, and rag2-/- stat1-/- mice were obtained from Taconic Farms (Germantown, NY). PML-/- mice were obtained from the National Cancer Institute (Frederick, MD). IFN-alpha/beta receptor-knockout (ifnar-/-) mice and ifnar-/- ifngr-/- mice were obtained from B & K Universal Ltd. (East Yorkshire, United Kingdom). Rag2-/- ifnar-/- mice were generously provided by Nicole Meissner and Allen Harmsen (Montana State University, Bozeman). Prior to viral inoculation, mice were anesthetized by i.p. administration of xylazine (7 mg/kg) and ketamine (100 mg/kg). Mice were inoculated by scarifying the cornea with a 26-gauge needle and by placing 4 mul complete DMEM containing 2 x 105 pfu of virus on each eye.
###end p 113
###begin p 114
###xml 421 423 421 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 453 455 453 455 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 40 44 <span type="species:ncbi:10090">mice</span>
###xml 139 145 <span type="species:ncbi:3635">cotton</span>
###xml 397 402 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
Viral titers in the ocular tear film of mice were determined at times after inoculation by swabbing the ocular surface of both eyes with a cotton-tipped applicator, and transferring the tip into 0.4 ml complete DMEM. Viral titers were determined by a 96-well plate plaque assay on the appropriate cell line cultured in complete DMEM containing 0.5% methlycellulose (i.e., Vero cells for wild-type HSV-1, L7 cells for ICP0- mutants, and E5 cells for ICP4- mutants).
###end p 114
###begin p 115
Titers of infectious virus in homogenates of whole eyes, trigeminal ganglia (TG), or hindbrain were determined by homogenizing tissues in 0.5 ml complete DMEM with a Pro 200 homogenizer (Pro Scientific, Oxford, CT), removing cell debris via centrifugation, and titering 10-fold serial dilutions of clarified supernatant on 24-well plates containing Vero or L7 cells. For all plaque assays, virus-infected cells were cultured in complete DMEM containing 0.5% methlycellulose for two to three days before staining with 20% methanol and 0.5% crystal violet.
###end p 115
###begin p 116
###xml 198 202 198 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink">10+ </sup>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 63 66 <span type="species:ncbi:10298">KOS</span>
###xml 610 614 <span type="species:ncbi:10090">mice</span>
###xml 653 657 <span type="species:ncbi:10090">mice</span>
GFP fluorescence in eyes, TG, and brains of mice infected with KOS-GFP was visualized on a Nikon TE2000 inverted fluorescent microscope (Nikon Instruments, Lewisville, TX) using a Jenoptik ProgRes C10+ Digital Camera (JenOptik Laser, Jena, Germany). Images were collected at 2x or 4x magnification using identical exposure conditions within a given comparison group, and composite images of the brain were created by stitching together photographs that covered the ventral surface of the brain using the graphics editor, Paint Shop Pro (Jasc Software, Eden Prairie, MN). GFP fluorescence in the eyes of living mice was obtained by placing anaesthetized mice on a petri dish on the stage of the microscope.
###end p 116
###begin title 117
###xml 12 17 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
Analysis of HSV-1 replication in vitro
###end title 117
###begin p 118
###xml 80 82 80 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 406 407 403 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 424 426 421 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 387 392 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 400 403 <span type="species:ncbi:10298">KOS</span>
Cultures of Vero cells were established in 12-well plates at a density of 2 x 105 cells per well and were cultured in complete DMEM. Cells were treated 24 hours later by replacing the culture medium with complete DMEM containing no IFN or 200 U/ml IFN-beta (PBL Biomedical Laboratories, Piscataway, NJ). Sixteen hours later, Vero cells were inoculated with 2.5 pfu per cell of wild-type HSV-1 strain KOS, 0--GFP, or the ICP4- virus n12. After allowing 45 minutes for adsorption, the inoculum was replaced with complete DMEM containing no IFN or 200 U/ml IFN-beta. Cultures were harvested 4.5, 9.0, 13.5, or 18.0 hours after inoculation by transfer to a -80degreesC freezer. Upon thawing, viral titers were determined by plaque assay on appropriate indicator cells.
###end p 118
###begin title 119
Dual labeling of trigeminal ganglion sections for LAT RNA and viral proteins
###end title 119
###begin p 120
###xml 247 251 247 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 480 481 477 478 <bold xmlns:xlink="http://www.w3.org/1999/xlink">1</bold>
###xml 486 488 483 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 516 517 513 514 <bold xmlns:xlink="http://www.w3.org/1999/xlink">2</bold>
###xml 530 532 527 529 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1215 1216 1193 1194 <bold xmlns:xlink="http://www.w3.org/1999/xlink">1</bold>
###xml 1268 1269 1246 1247 <bold xmlns:xlink="http://www.w3.org/1999/xlink">2</bold>
###xml 1299 1300 1277 1278 <bold xmlns:xlink="http://www.w3.org/1999/xlink">3</bold>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
###xml 397 401 <span type="species:ncbi:10090">mice</span>
###xml 623 628 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 1281 1287 <span type="species:ncbi:9986">rabbit</span>
###xml 1322 1328 <span type="species:ncbi:9986">rabbit</span>
###xml 1422 1428 <span type="species:ncbi:9986">rabbit</span>
Mice were euthanized and perfused with 0.1 M phosphate-buffered saline (PBS) followed by 4% paraformaldehyde. The six TG from each group of mice were immersed in 4% paraformaldehyde for 1 hour, equilibrated with 30% sucrose, embedded in Tissue-Tek(R) O.C.T. compound (Sakura Finetechnical, Tokyo, Japan), and frozen in liquid nitrogen. Each block of tissue containing the six TG from one group of mice was cut into ~160 sections of 7 muM thickness. Slides were processed to label 1. LAT+ neurons with rhodamine, and 2. HSV antigen+ neurons with fluorescenin, as follows. LAT riboprobes, specific for bases 119629-119975 of HSV-1, were prepared at 37degreesC with digoxigenin RNA Labeling Mix (Roche, Mannheim, Germany). LAT riboprobe synthesis reactions were treated with DNase I and filtered through a Sephadex G-50 column prior to use. Tissue sections were incubated in a pre-hybridization buffer, and then hybridized to LAT-specific riboprobes by an overnight 45degreesC incubation. Tissue was washed with 2x SSC, treated with 20 mug/ml of RNase A in 2x SSC at 37degreesC, followed by serial washes in 0.5x SSC and 0.1x SSC. Tissue sections were equilibrated with 0.1 M PBS, and were sequentially incubated with 1. rhodamine-labeled anti-digoxigenin Fab fragments, 2. 3% normal rabbit serum, and 3. fluorescein-labeled rabbit polyclonal anti-HSV antibodies (DAKO Cytomation, Carpinteria, CA) diluted 1:100 in 1% normal rabbit serum. Fluorescent-labeled tissue sections were then washed with 0.1 M PBS, and mounted under cover slips.
###end p 120
###begin title 121
###xml 12 17 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
Analysis of HSV-1 reactivation in trigeminal ganglion explants
###end title 121
###begin p 122
###xml 292 294 286 288 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 384 386 372 374 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 514 516 502 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 1054 1056 1034 1036 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
Latently infected mice were sacrificed on days 38 and 39 p.i., TG were aseptically removed, and each TG was placed in one well of a 24-well plate containing 1 ml of complete DMEM. Once TG were harvested for an entire 24-well plate, the TG were heat stressed by transfer to a 43degreesC, 5% CO2 incubator for 3 hours. After heat stress, explants were transferred to a 37degreesC, 5% CO2 incubator. Twenty-four hours later, TG and cell culture medium were transferred to 24-well plates seeded 6 h earlier with 5 x 104 L7 cells per well in a volume of 0.5 ml of complete DMEM. On days 6 and 10 after explantation, TG were transferred to a 24-well plate containing freshly seeded L7 cells. After 14 days in culture, TG explants were homogenized in 500 mul of complete DMEM with a Pro 200 homogenizer (Pro Scientific) and TG homogenates were transferred to a -80degreesC freezer. Freeze-thawed TG homogenates were centrifuged to remove tissue debris, and 200 mul of clarified supernatant was used to inoculated each well of a 12-well plate of L7 cells (1 x 105 cells per well). After allowing 45 minutes for viral adsorption, the viral inoculum was aspirated, the cell monolayer was rinsed with 1 ml complete DMEM, and the rinse solution was replaced with 1 ml complete DMEM. Monolayers of L7 cells treated with TG homogenates were observed for six days for the development of viral cytopathic effects.
###end p 122
###begin title 123
###xml 15 20 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
Measurement of HSV-1 DNA load in latently infected mouse trigeminal ganglion
###end title 123
###begin p 124
###xml 224 226 218 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 32 37 <span type="species:ncbi:10090">mouse</span>
###xml 247 252 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
The left and right TG from each mouse were placed into a single 1.5 ml microfuge tube, and transferred to -80degreesC until the time of DNA extraction. DNA was isolated by a standard phenol: chloroform extraction procedure [59], and the number of HSV-1 genomes per TG was determined by a competitive PCR assay, which is described as follows.
###end p 124
###begin p 125
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 440 455 440 455 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GGAGGACCGAAGGAG</underline>
###xml 500 515 500 515 <underline xmlns:xlink="http://www.w3.org/1999/xlink">CCAGTGCTGCAATGA</underline>
###xml 175 180 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
The oligonucleotide primers used in the competitive PCR assay, VP16-a (5'-GGACTCGTATTCCAGCTTCAC-3') and VP16-b (5'-CGTCCTCGCCGTCTAAGTG-3'), amplified a 260-bp fragment of the HSV-1 VP16 gene. To provide an internal control for each PCR assay, a VP16 competitor template was generated by the method of Siebert and Larrick [60]. In brief, an irrelevant sequence from pUC18 was amplified with the primers VP16 mimic-a (5'-GGACTCGTATTCCAGCTTCACGGAGGACCGAAGGAG-3') and VP16 Mimic-b (5'-CGTCCTCGCCGTCTAAGTGCCAGTGCTGCAATGA), which amplify a 361-bp PCR product whose 5' ends are identical in sequence to the VP16-a and VP16-b primers. The VP16 competitor was cloned into the pCR II vector (Invitrogen Corp., Carlsbad, CA), and the resulting plasmid was used as a competitor template in the competitive PCR assay. DNA for the standard curve was obtained by diluting the plasmid pCRII: VP16 into a solution of TE buffer containing 33 ng/mul of salmon sperm DNA as carrier DNA. The most concentrated standard contained 45 fg of plasmid DNA per mul (10,000 copies per mul), and 13-serial twofold dilutions were made using TE buffer and salmon sperm DNA as the diluent.
###end p 125
###begin p 126
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq </italic>
###xml 489 493 479 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq </italic>
PCR assays were conducted as follows: A solution containing 1x Taq buffer, 50 muM of each dNTP, 0.25 muM of each VP16 primer, 5% glycerol, and ~1500 copies of VP16 competitor template per 50 mul reaction was prepared. Forty-two microliters of this master mix were placed in 0.65 ml tubes and overlaid with mineral oil, and 100 ng of TG DNA (3 mul), DNA standards, or negative control DNA sample was added to each tube. The tubes were heated to 90degreesC in a thermal cycler, and 2.5 U of Taq polymerase diluted in 5 mul of Taq buffer was added to each sample. PCR samples were incubated for 35 cycles of 94degreesC for 1 minute 15 seconds, 59.5degreesC for 1 minute 15 seconds, and 72degreesC for 40 seconds.
###end p 126
###begin p 127
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 622 624 605 607 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 1023 1025 1002 1004 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 1249 1250 1222 1223 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1252 1253 1225 1226 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
Measurement of VP16 gene and competitor PCR product yields was performed by a modification of the dot blot procedure of Hill et al. [61]. From each amplified PCR sample, 15 mul was diluted in 500 mul of a 0.4 M NaOH solution, transferred to a 0.6 ml microfuge tube, heated to 90degreesC for 10 minutes, snap-cooled on ice, and blotted on Zeta Probe GT nylon membrane (BioRad Laboratories, Hercules, CA) in an 8 x 12 dotblot pattern using a Convertibletrade mark vacuum filtration manifold (Whatman-Biometra, Groningen, Germany). Two identical dotblots of each set of PCR samples were produced and crosslinked with 0.2 J/cm2 in a UV crosslinker (Spectronics Corporation, Westbury, NY). One dotblot was hybridized to a radiolabeled oligonucleotide specific for VP16 (5'-GTCGTCGTCCGGGAGATCGAGCAGGCCCTC-3'), and the second duplicate dotblot was hybridized to a radiolabeled oligonucleotide specific for the competitor PCR product (5'-CGCTCGTCGTTTGGTATGGCTTCATTCAGC-3'). Both oligonucleotide probes were end-labeled with [alpha-32P] dATP using terminal deoxynucleotidyl transferase (Promega Corporation, Madison, WI). Each probe was allowed 16 h to hybridize to a membrane at 42degreesC in a solution containing 20 ng/ml labeled probe, 7% SDS, 120 mM NaH2PO4, and 250 mM NaCl. Excess probe was removed from membranes by sequential rinses in 0.1x standard saline citrate (SSC) containing 0.1% SDS and membranes were exposed to phosphor screens, which were scanned on a Cyclone PhosphorImager (Perkin Elmer Life Sciences, Boston, MA). The amount of radolabeleled probe hybridized to each dotblot was determined using OptiQuant v4.0 software (Perkin Elmer Life Sciences).
###end p 127
###begin p 128
###xml 432 434 432 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3 </sup>
###xml 438 440 438 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 519 521 519 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 913 916 910 913 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
###xml 591 596 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 963 968 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
A two-fold dilution series of VP16 plasmid DNA defined the relationship between the copy number of VP16 genes in each PCR (x) and the logarithm of the ratio of VP16 to competitor PCR product yields (y) amplified from each DNA sample. The standard curve was described by the equation x = arctanh (y), but for convenience Microsoft Excel's trendline-fitting feature was used to rapidly define a third order polynomial equation (x = ay3 + by2 + cy + d) that approximates the sigmoid shape described by this equation (Fig. 8B). To estimate the copy number of viral genomes per TG, the number of HSV-1 genomes per PCR was multiplied times 150. This derivation is based on the fact that an average of 15 mug of DNA is extracted from each TG pair using an extraction procedure that recovers 50% of the total DNA. Thus, ~15 mug of DNA was present in a single TG, and the input of 0.1 mug of TG DNA per PCR contains ~1/150th (0.1 mug out of 15 mug) of the total number of HSV-1 genomes present in a single TG.
###end p 128
###begin title 129
Statistics
###end title 129
###begin p 130
###xml 508 512 508 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 512 516 512 516 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 522 527 522 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 527 531 527 531 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 544 548 544 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 548 552 548 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 552 557 552 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 557 561 557 561 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 502 506 <span type="species:ncbi:10090">mice</span>
###xml 516 520 <span type="species:ncbi:10090">mice</span>
###xml 531 535 <span type="species:ncbi:10090">mice</span>
###xml 561 565 <span type="species:ncbi:10090">mice</span>
Analysis of numerical data was performed with the software packages Microsoft Excel and Modstat (Modern Microcomputers, Mechanicsville, VA). All viral titers were transformed by adding a value of 1 to the number of plaque-forming units detected per sample, such that all data could be analyzed on a logarithmic scale. The significance of differences between multiple groups was evaluated by one-way analysis of variance followed by a post hoc t-test. The significance of differences between strain 129 mice, rag2-/- mice, stat1-/- mice, versus rag2-/- stat1-/- mice was evaluated by two-way analysis of variance. The goodness of fit of the standard curve used in the competitive PCR assay was determined by regression analysis using the method of least squares.
###end p 130
###begin title 131
Abbreviations
###end title 131
###begin p 132
GFP: green fluorescent protein
###end p 132
###begin p 133
HSV: herpes simplex virus
###end p 133
###begin p 134
ICP: infected cell protein
###end p 134
###begin p 135
IFNAR: interferon-alpha/beta receptor
###end p 135
###begin p 136
IFNGR: interferon-gamma receptor
###end p 136
###begin p 137
LAT: latency-associated transcript
###end p 137
###begin p 138
L/ST: long-short spanning transcript
###end p 138
###begin p 139
p.i.: post inoculation
###end p 139
###begin p 140
PML: promyelocytic leukemia
###end p 140
###begin p 141
PKR: protein kinase R
###end p 141
###begin p 142
RAG2: recombination-activated gene 2
###end p 142
###begin p 143
###xml 1 2 1 2 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
RL: long-repeated
###end p 143
###begin p 144
SCID: severe-combined immunodeficiency
###end p 144
###begin p 145
Stat 1: signal transducer and activator of transcription 1
###end p 145
###begin p 146
TG: trigeminal ganglia
###end p 146
###begin title 147
Competing interests
###end title 147
###begin p 148
The author(s) declare that they have no competing interests.
###end p 148
###begin title 149
Authors' contributions
###end title 149
###begin p 150
###xml 105 110 105 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scid </italic>
###xml 120 125 120 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scid </italic>
###xml 134 138 134 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 148 153 148 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 153 157 153 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 198 206 198 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 223 228 223 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 228 232 228 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 238 243 238 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifngr</italic>
###xml 243 247 243 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 253 257 253 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 257 261 257 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 267 272 267 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 272 276 272 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 282 286 282 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 286 290 286 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 290 295 290 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stat1</italic>
###xml 295 299 295 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 305 310 305 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 310 314 310 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 320 325 320 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 325 329 325 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 329 334 329 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifngr</italic>
###xml 334 338 334 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 348 352 348 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rag2</italic>
###xml 352 356 352 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 356 361 356 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifnar</italic>
###xml 361 365 361 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 405 407 405 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 415 416 415 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 569 577 569 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 602 604 602 604 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 650 652 650 652 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 674 683 674 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 719 721 719 721 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 734 736 734 736 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
###xml 125 129 <span type="species:ncbi:10090">mice</span>
###xml 138 142 <span type="species:ncbi:10090">mice</span>
###xml 157 161 <span type="species:ncbi:10090">mice</span>
###xml 232 236 <span type="species:ncbi:10090">mice</span>
###xml 247 251 <span type="species:ncbi:10090">mice</span>
###xml 261 265 <span type="species:ncbi:10090">mice</span>
###xml 276 280 <span type="species:ncbi:10090">mice</span>
###xml 299 303 <span type="species:ncbi:10090">mice</span>
###xml 314 318 <span type="species:ncbi:10090">mice</span>
###xml 338 342 <span type="species:ncbi:10090">mice</span>
###xml 365 369 <span type="species:ncbi:10090">mice</span>
###xml 476 479 <span type="species:ncbi:10298">KOS</span>
WPH conceived of the study and wrote the manuscript. WPH, DJJC, and BMG carried out pilot experiments in scid mice, NOD scid mice, PML-/- mice, and stat1-/- mice. WPH and JG carried out most of the in vivo experiments with stat1-/- mice, ifngr-/- mice, rag2-/- mice, stat1-/- mice, rag2-/- stat1-/- mice, ifnar-/- mice, ifnar-/- ifngr-/- mice, and rag2-/- ifnar-/- mice. MS made and characterized the ICP0- virus, 0--GFP. JB constructed and characterized the wild-type virus, KOS-GFP. TPS and YI performed double labeling of trigeminal ganglia sections via fluorescent in situ hybridization for LAT RNA+ neurons and antibody staining of viral antigen+ neurons. CW performed in vitro comparisons of growth curves of ICP0- null and ICP4- null viruses in the presence or absence of interferon-beta.
###end p 150
###begin title 151
Acknowledgements
###end title 151
###begin p 152
This work was supported by grants from the National Institutes of Health (R01 AI51414) and the National Center for Research Resources (P20 RR-020185-01). Dr. William Halford is supported by a National Science Foundation EPSCoR grant to Montana State University (EPS 0346458) and the Montana Agricultural Experiment Station. The authors thank Francis Carbone, Roger Everett, Michele Hardy, and Chris Preston for their thoughtful and critical evaluation of this manuscript, and thank Justin Patrick for outstanding technical assistance.
###end p 152
###begin article-title 153
Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins
###end article-title 153
###begin article-title 154
The latency-associated transcripts of herpes simplex virus: RNA in search of function
###end article-title 154
###begin article-title 155
###xml 73 100 <span type="species:ncbi:10298">herpes simplex virus type 1</span>
A virus with a mutation in the ICP4-binding site in the L/ST promoter of herpes simplex virus type 1, but not a virus with a mutation in open reading frame P, exhibits cell-type-specific expression of gamma(1)34.5 transcripts and latency-associated transcripts
###end article-title 155
###begin article-title 156
###xml 48 75 <span type="species:ncbi:10298">herpes simplex virus type 1</span>
Effect of the transcription start region of the herpes simplex virus type 1 latency-associated transcript promoter on expression of productively infected neurons in vivo
###end article-title 156
###begin article-title 157
A viral activator of gene expression functions via the ubiquitin-proteasome pathway
###end article-title 157
###begin article-title 158
Repression of viral transcription during herpes simplex virus latency
###end article-title 158
###begin article-title 159
###xml 102 129 <span type="species:ncbi:10298">herpes simplex virus type 1</span>
Regulation of eIF2alpha phosphorylation by different functions that act during discrete phases in the herpes simplex virus type 1 life cycle
###end article-title 159
###begin article-title 160
Phosphorylation and dephosphorylation events that regulate viral mRNA translation
###end article-title 160
###begin article-title 161
Expression of herpes simplex virus ICP0 inhibits the induction of interferon-stimulated genes by viral infection
###end article-title 161
###begin article-title 162
The herpes simplex virus ICP0 RING finger domain inhibits IRF3- and IRF7-mediated activation of interferon-stimulated genes
###end article-title 162
###begin article-title 163
Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene
###end article-title 163
###begin article-title 164
A road map for those who know JAK-STAT
###end article-title 164
###begin article-title 165
Signaling through the JAK/STAT pathway, recent advances and future challenges
###end article-title 165
###begin article-title 166
The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon-alpha/beta
###end article-title 166
###begin article-title 167
Herpes simplex virus ICP0 mutants are hypersensitive to interferon
###end article-title 167
###begin article-title 168
Herpes simplex virus ICP0 and ICP34.5 counteract distinct interferon-induced barriers to virus replication
###end article-title 168
###begin article-title 169
Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo
###end article-title 169
###begin article-title 170
###xml 77 99 <span type="species:ncbi:10298">herpes simplex virus 1</span>
Amino acid substitutions in the effector domain of the gamma 34.5 protein of herpes simplex virus 1 have differential effects on viral response to interferon-alpha
###end article-title 170
###begin article-title 171
###xml 58 85 <span type="species:ncbi:10298">herpes simplex virus type 1</span>
Bioluminescence imaging reveals systemic dissemination of herpes simplex virus type 1 in the absence of interferon receptors
###end article-title 171
###begin article-title 172
Interplay between Alpha/Beta and Gamma Interferons with B, T, and Natural Killer Cells in the Defense against Herpes Simplex Virus Type 1
###end article-title 172
###begin article-title 173
Promyelocytic Leukemia Protein Mediates Interferon-Based Anti-Herpes Simplex Virus 1 Effects
###end article-title 173
###begin article-title 174
###xml 24 51 <span type="species:ncbi:10298">herpes simplex virus type 1</span>
###xml 107 112 <span type="species:ncbi:10090">mouse</span>
Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains
###end article-title 174
###begin article-title 175
Optimized viral dose and transient immunosuppression enable herpes simplex virus ICP0-null mutants to establish wild-type levels of latency in vivo.
###end article-title 175
###begin article-title 176
###xml 47 74 <span type="species:ncbi:10298">herpes simplex virus type 1</span>
ICP0 is required for efficient reactivation of herpes simplex virus type 1 from neuronal latency
###end article-title 176
###begin article-title 177
Recurrent herpes simplex virus hepatitis after liver retransplantation despite acyclovir therapy
###end article-title 177
###begin article-title 178
Mathematical analysis demonstrates that interferons-beta and -gamma interact in a multiplicative manner to disrupt herpes simplex virus replication.
###end article-title 178
###begin article-title 179
Interferon-beta and interferon-gamma synergize to block viral DNA and virion synthesis in herpes simplex virus-infected cells.
###end article-title 179
###begin article-title 180
###xml 0 27 <span type="species:ncbi:10298">Herpes simplex virus type 1</span>
###xml 108 112 <span type="species:ncbi:10090">mice</span>
Herpes simplex virus type 1 mutant strain in1814 establishes a unique, slowly progressing infection in SCID mice
###end article-title 180
###begin article-title 181
###xml 28 33 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
A thymidine kinase-negative HSV-1 strain establishes a persistent infection in SCID mice that features uncontrolled peripheral replication but only marginal nervous system involvement
###end article-title 181
###begin article-title 182
ICP0, a regulator of herpes simplex virus during lytic and latent infection
###end article-title 182
###begin article-title 183
###xml 85 112 <span type="species:ncbi:10298">herpes simplex virus type 1</span>
ICP0, ICP4, or VP16 expressed from adenovirus vectors induces reactivation of latent herpes simplex virus type 1 in primary cultures of latently infected trigeminal ganglion cells
###end article-title 183
###begin article-title 184
RNA complementary to a herpesvirus a gene mRNA is prominent in latently infected neurons
###end article-title 184
###begin article-title 185
Herpes simplex virus latency-associated transcript is a stable intron
###end article-title 185
###begin article-title 186
Cell type and cell state determine differential in vitro growth of non-neurovirulent ICP34.5-negative herpes simplex virus types 1 and 2
###end article-title 186
###begin article-title 187
###xml 19 46 <span type="species:ncbi:10298">herpes simplex virus type 1</span>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
###xml 144 149 <span type="species:ncbi:10090">mouse</span>
ICP34.5 mutants of herpes simplex virus type 1 strain 17syn+ are attenuated for neurovirulence in mice and for replication in confluent primary mouse embryo cell cultures
###end article-title 187
###begin article-title 188
A herpesvirus genetic element which affects translation in the absence of the viral GADD34 function
###end article-title 188
###begin article-title 189
###xml 4 31 <span type="species:ncbi:10298">herpes simplex virus type 1</span>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
The herpes simplex virus type 1 strain 17+ gamma 34.5 deletion mutant 1716 is avirulent in SCID mice
###end article-title 189
###begin article-title 190
###xml 127 131 <span type="species:ncbi:10090">mice</span>
Precipitous clearance of herpes simplex virus antigens from the peripheral nervous systems of experimentally infected C57BL/10 mice
###end article-title 190
###begin article-title 191
###xml 25 52 <span type="species:ncbi:10298">herpes simplex virus type 1</span>
###xml 54 59 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons
###end article-title 191
###begin article-title 192
Immunity to latent viral infection: many skirmishes but few fatalities
###end article-title 192
###begin article-title 193
Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript
###end article-title 193
###begin article-title 194
###xml 0 27 <span type="species:ncbi:10298">Herpes simplex virus type 1</span>
Herpes simplex virus type 1 latency-associated transcript gene promotes neuronal survival
###end article-title 194
###begin article-title 195
###xml 0 27 <span type="species:ncbi:10298">Herpes simplex virus type 1</span>
Herpes simplex virus type 1 latency-associated transcript expression protects trigeminal ganglion neurons from apoptosis
###end article-title 195
###begin article-title 196
###xml 38 65 <span type="species:ncbi:10298">herpes simplex virus type 1</span>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice
###end article-title 196
###begin article-title 197
Detection and quantification of the rare latently infected cell undergoing herpes simplex virus transcriptional activation in the nervous system in vivo
###end article-title 197
###begin article-title 198
###xml 97 102 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 123 134 <span type="species:ncbi:10141">guinea pigs</span>
Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs
###end article-title 198
###begin article-title 199
Vaccines against genital herpes: progress and limitations
###end article-title 199
###begin article-title 200
Studies of the natural history of herpes simplex virus infections
###end article-title 200
###begin article-title 201
Epidemiology of genital herpes
###end article-title 201
###begin article-title 202
###xml 18 23 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
Immune control of HSV-1 latency
###end article-title 202
###begin article-title 203
Immune control of herpes simplex virus during latency
###end article-title 203
###begin article-title 204
Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins
###end article-title 204
###begin article-title 205
###xml 0 27 <span type="species:ncbi:10298">Herpes simplex virus type 1</span>
Herpes simplex virus type 1 ICP0 plays a critical role in the de novo synthesis of infectious virus following transfection of viral DNA.
###end article-title 205
###begin article-title 206
###xml 4 31 <span type="species:ncbi:10298">herpes simplex virus type 1</span>
The herpes simplex virus type 1 regulatory protein ICP0 enhances virus replication during acute infection and reactivation from latency.
###end article-title 206
###begin article-title 207
###xml 54 81 <span type="species:ncbi:10298">herpes simplex virus type 1</span>
Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4
###end article-title 207
###begin article-title 208
###xml 36 63 <span type="species:ncbi:10298">herpes simplex virus type 1</span>
Re-evaluating natural resistance to herpes simplex virus type 1
###end article-title 208
###begin article-title 209
Green fluorescent protein is a quantitative reporter of gene expression in individual eukaryotic cells
###end article-title 209
###begin article-title 210
###xml 42 69 <span type="species:ncbi:10298">herpes simplex virus type 1</span>
Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture.
###end article-title 210
###begin article-title 211
Preparation and analysis of DNA, p.2.0.3-2.2.3
###end article-title 211
###begin article-title 212
PCR MIMICS: competitive DNA fragments for use as internal standards in quantitative PCR
###end article-title 212
###begin article-title 213
Quantitative analysis of polymerase chain reaction products by dot blot
###end article-title 213
###begin article-title 214
###xml 34 39 <span type="species:ncbi:10090">mouse</span>
Gene for the catalytic subunit of mouse DNA-dependent protein kinase maps to the scid locus.
###end article-title 214
###begin article-title 215
Role of PML in cell growth and the retinoic acid pathway
###end article-title 215
###begin article-title 216
###xml 16 20 <span type="species:ncbi:10090">mice</span>
RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement
###end article-title 216
###begin article-title 217
###xml 19 23 <span type="species:ncbi:10090">mice</span>
Immune response in mice that lack the interferon-gamma receptor
###end article-title 217
###begin article-title 218
Functional role of type I and type II interferons in antiviral defense
###end article-title 218
###begin article-title 219
###xml 21 25 <span type="species:ncbi:10090">mice</span>
Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors
###end article-title 219
###begin article-title 220
###xml 41 45 <span type="species:ncbi:10090">mice</span>
Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway
###end article-title 220

